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ABSTRACT 
V 
DNA immunization, or the use of antigen-expressing DNAs to raise immune 
responses, represents a novel approach to the study and manipulation of immune 
responses. In this dissertation, we examine the role of antigen expression at the target 
· site, the role of antigen presentation by bone marrow-derived cells, and the effect of 
secretion of antigen on DNA-raised responses in mice. Immunizations were conducted 
using either gene gun delivery of DNA to the epidermis or intramuscular (i.m.) saline 
injections. 
To examine the role of antigen expression at the target site, we excised target sites 
at different time points following immunization. We immunized with plasmid DNA 
expressing three different forms of antigens: influenza hemagglutinin Hl, human growth 
hormone and influenza nucleoprotein NP (membrane-bound, secreted and intracellular, 
respectively). We hypothesized that antigen expression at the target site would be 
essential in initiating immune responses. We demonstrate here that the target site plays 
different roles in gene gun and i.m. immunizations. We found that the skin target site 
VI 
played an essential role in eliciting maximal antibody and cytotoxic T lymphocyte (CTL) 
responses by gene gun immunization, although low-level responses can be raised 
independent of the target site. In contrast, the muscle target site was not essential for 
eliciting maximal immune responses following i.m. immunization. We suggest that gene 
gun immunization results in transfection of keratinocytes and bone marrow-derived 
Langerhans cells at the target site, and these cells together initiate maximal responses. In 
i.m. immunizations, on the other hand, nonmuscle cells at distal sites, perhaps bone 
marrow-derived cells in lymphoid tissues, become transfected and are sufficient for 
initiation of maximal responses. 
We also examined the role of antigen presentation by bone marrow-derived cells 
m initiation of CTL responses to influenza NP following gene gun and i.m. 
immunization. We hypothesized that antigen presentation by bone marrow-derived cells 
would be involved in initiation of CTL responses. To test this hypothesis, irradiated Fl 
mice of :Ml-IC class I H-2bxd haplotype were reconstituted with bone marrow from either 
H-2b or H-2d donors, creating two sets of bone marrow chimeric mice (H-2b ➔ H-2bxd 
and H-2d ➔ H-2bxd, respectively). We immunized the two sets of bone marrow chimeric 
mice and determined the :Ml-IC haplotype restriction of the induced CTL responses using 
H-2b- or H-2d-restricted peptides of NP. We found that the CTL responses initiated 
following gene gun and i.m. immunization were restricted to the haplotype of the bone 
marrow donor. In H-2b ➔ H-2bxd chimeric mice, CTL responses were restricted to H-2\ 
while in H-2d ➔ H-2bxd chimeric mice, CTL responses were restricted to H-2d. Thus, 
Vll 
antigen presentation by bone marrow-derived cells, and not by skin or muscle cells, 
initiates CTL responses following both gene gun and i.m. immunization. 
Finally, we examined the effect of secretion of a DNA-expressed antigen on 
antibody responses. We hypothesized that a secreted antigen would raise greater antibody 
responses than a membrane-bound antigen, due to easier access of a soluble antigen to 
lymphoid tissues and to uptake by professional antigen-presenting cells and by antigen-
specific B cells. We immunized mice with plasmid DNA expressing either a secreted or 
the normal membrane-bound form of influenza hemagglutinin Hl. We found that 
secretion ofHl (sHl) did not result in enhanced antibody responses, with sHl appearing 
to be less effective than HI. We suggest that the effectiveness of DNA immunization 
with membrane-bound HI in raising maximal antibody responses may be due to MHC 
class II presentation of Hl via an endogenous pathway, resulting from direct transfection 
of bone marrow-derived APCs. 
We also found that secretion of Hl influenced the predominant IgG subclass of 
antibody responses raised by i.m. immunization. Secreted HI raised predominantly IgGl 
responses and Hl raised predominantly lgG2a responses. The IgG 1 response to sHl 
following i.m. immunization was IL-4 dependent, suggesting that the response to sHl 
had a T-helper type 2 phenotype. 
We propose a model for the mechanism of initiation of immune responses by 
DNA immunization based on our results and taking them within the context of results 
from other investigators in the field. We propose that DNA immunization may initiate 
immune responses primarily by the direct transfection of bone marrow-derived cells that 
Vlll 
then express and present the DNA vaccine-encoded antigen. However, antigen expression 
by nonhemopoietic cells, particularly in skin, may play a role in raising maximal 
responses. 
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Construction, preparation and delivery of DNA vaccines 
DNA immunization uses plasmid expression vectors that encode antigens. These 
plasmids, or DNA vaccines, are inoculated into an animal, and the antigen is expressed 
by cells that are transfected with the vaccine. An immune response is then mounted 
against the DNA vaccine-encoded antigen (reviewed by Robinson and Torres, 1997). 
A DNA vaccine is constructed by taking a sequence encoding an immunogen and 
placing this in a plasmid vector (Figure 1, A and B). Commonly used plasmid vectors 
place this antigen-encoding sequence under the control of a mammalian promoter, such 
as that from the cytomegalovirus. (CMV) immediate early region (Figure 2). Other 
control sequences often used in DNA vaccines are enhancer sequences, the CMV intron 
A, and a transcription terminator with a polyadenylation sequence, usually from the 
bovine growth hormone gene (Hartikka et al, 1996; Montgomery, 1993). The intron A 
sequence has been effective in maximizing expression of microbial cDNA, perhaps by 
enhancing the rate of RNA polyadenylation and splicing and by providing nuclear 
transport signals that are absent in prokaryotic mRNA (Hartikka et al, 1996). For weaker 
expression of potentially toxic proteins, the SV 40 promoter and polyadenylation 
sequence have been used (Xiang et al, 1994). Vaccine plasmids have a prokaryotic origin 
of replication that is not functional in eukaryotic cells, and contain an antibiotic resistance 
gene to allow for selection in E. coli. Bacteria are transformed with the DNA vaccine 









Figure 1. Preparation of DNA vaccines. See text for details. 
4 
A 8 
Vaccine insert Vaccine inse.rt 
Figure 2. Plasmid vectors used for DNA vaccines . Schematic diagrams of commonly used plasmids for 
DNA immunization, with either one (A) or two (B) DNA vaccine inserts. CMV-IA - cytomegalovirus 
promot er with Intron A:, BGH - bovine growth hormone polyadenylation sequence; asterisks indicate 
positions of immuno stimulatory sequences (ISS) 
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The va.Ji ne is purified, then inoculated into the animal by one of several methods 
(Figure ID). DNA vaccines may be used as free plasmid DNA (i.e. 'naked ' DNA) or in 
association with a delivery vehicle such as a lipid carrier. They may be inoculated into 
the animal by intramuscular (i.m.) or intradermal (i.d.) injections in saline; or by particle-
mediated delivery, or gene gun (Figure 3), where the plasmid DNA is coated onto the 
surface of microscopic gold beads that are then delivered into the epidermis of the animal 
by a pulse of compressed helium gas (Tang et al, 1992). DNA vaccines may be delivered 
onto mucosal surfaces in association with liposomes (Gregoriadis et al, 1997), cationic 
lipids (Wheeler et al, 1996), in microspheres (Jones et al, 1997), or by using attenuated 
strains of Shigella (Sizemore et al, 1997). 
Advantages in using DNA vaccines over conventional vaccines 
Comparison of DNA vaccines with subunit and live attenuated vaccines. DNA 
vaccines act similarly to subunit vaccines while mimicking live attenuated vaccines. A 
DNA vaccine encodes only a specific protein component of a pathogen, and not the 
whole pathogen, which makes it similar to a subunit vaccine. Like subunit vaccines, 
DNA vaccines are able to raise antibody responses. However, unlike a subunit vaccine, 
the DNA vaccine-encoded antigen is endogenously synthesized in the cells of the animal, 
mimicking a live virus infection. Endogenous synthesis of an antigen results in its 
presentation via the MHC class I pathway (Maffei et al, 1997). Presentation in the context 
of MHC class I activates CDS-positive T cells, which can become effector cytolytic T 
I I I ••• .. ~§ .. -~ + ••• + 
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Figure 3, Particle-mediated delivery (gene gun) of DNA vaccines. Purified plasmid DNA vaccines (A) are precipitated onto microscopic gold beads 
(B). The DNA-coated gold beads are coated onto the iMer surface of a plastic tubing that is cut into individual tube shots (C) . The tube shots are loaded 
onto th~ chanm:r (D) of the Accell® gene gun (E) and delivered onto the mouse skin. 
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lymphocytes (CTL; Townsend and Bodmer, 1989). By mimicking a live virus infection, 
DNA vaccines are able to raise CTL responses in the absence of infection and the risk of 
vaccine-induced disease. 
Comparison of DNA vaccines with viral vector vaccines. Viral vector vaccines 
are closely related to DNA vaccines. They both direct the endogenous synthesis of an 
antigen of interest in transfected or transduced (in the case of viral vectors) cells, and thus 
can both induce CTL responses. However, in contrast with viral vector vaccines, DNA 
vaccines encode for only the antigen of interest, while viral vector vaccines encode 
several proteins of the virus used as vector (Davis et al, 1995; Berns and Giraud, 1995). 
Immune responses can thus be raised against the vector itself, making secondary 
immunizations with the vector either useless or harmful. In addition, retroviral vectors 
can integrate into the genome, adding to the risk of using viral vectors. 
Ease and low cost of production of DNA vaccines. DNA vaccines are simple to 
produce in large quantities at relatively low cost, compared to subunit, live attenuated and 
viral vector vaccines. Conventional methods available to most laboratories around the 
world for growing and amplifying plasmid DNA in bacteria, and for subsequent plasmid 
purification, are all that is required for DNA vaccine production . Furthermore , unlike 
conventional vaccines that require refrigeration for storage and transport ('cold-chain '), 
DNA vaccines in lyophilized form are stable over a broad range of temperatures. Prior to 
vaccination, the lyophilized DNA need only be resuspended in normal saline solution, 
and it is ready for injection . This makes DNA vaccines ideal for immunizations m 
developing countries, where costs for the ' cold-chain' can be prohibitive. 
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Manipulation of immune responses raised by DNA vaccines 
A consequential advantage of using DNA vaccines over conventional vaccine s is 
that it allows vaccinologists to manipulate the specificity , T-helper type and magnitude of 
the immune response elicited by DNA with the use of recombinant DNA technology . 
Sequences of DNA vaccines can be modified to express antigens with certain desired 
properties , as described below. 
DNA vaccines expressing epitopes . DNA vacci nes have been prepared which 
encode immuno dominant epitopes or specific epitopes , rather than the complete antigen 
(Ciernik et al, 1996; Tho mson et al, 1998). Immuni zation with epitopes rather than whole 
antigens can be advantageous for pathogens that have multipl e seroty pes, such as 
influenza, and for pathogens that have multiple variant epitope s, such as human 
immunodeficiency virus, or HIV (Suhrbier , 1997). DNA vaccines expressing epitopes are 
easier to prepare and purify than epitopes delivered as peptides , and allow the co-
expression of immunomodulat ory cytokines . In addition, DNA vaccines allow delivery of 
multiple epitopes without the risk of tolerizi ng the animal with large doses of peptides , 
and in the absence of antigenic competit ion resulting from immunization with multiple 
whole antigens. 
Modifving antigen-encoding sequ ences , Sequences that modify properties of the 
DNA vaccine-encod ed antigen such as stabil ity and cellular local ization can also be 
added onto DNA vaccines . Sequences that lead to ubiquitination of the antigen have been 
added to favor antigen degradatio n in pro teaso mes and subse quent :MHC class I 
presentation (Rodriguez et al, 1997 ; Wu and Kipps, 1997). Rapid degradatio n of 
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ubiquitinated DNA vaccine-encoded antigens has resulted in enhanced CTL responses, as 
might be expected from enhanced antigen presentation by MHC class I. Antibody 
responses, however, are eliminated by these modifications, since whole antigens are not 
expressed in sufficient quantities. Localization sequences such as secretion signals 
(Haddad et al, 1997; Ertl et al, 1995; Gardner et al., 1996), endoplasmic• reticulum (ER) 
retention sequences and membrane anchors (Boyle et al, 1997) have been added onto 
DNA vaccines to express, respectively, secreted, ER-retained and membrane-bound 
forms of antigens. These different forms have either increased, decreased or did not 
change antibody and CTL responses, depending on the antigen. DNA vaccines have also 
been constructed where wild-type codons of a viral protein were replaced with codons 
from high-expressing human genes, resulting in greater antigen expression and enhanced 
immune responses (Andre et al, 1998). 
Addition of immunomodulatory sequences. Immunomodulatory sequences can 
also be engineered onto DNA vaccines. Sequences encoding cytokines or costimulatory 
molecules have been added to DNA vaccines in order to enhance responses (reviewed by 
Pasquini et al, 1997). Addition of sequences encoding the cytokines granulocyte-
macrophage colony-stimulating factor (GM-CSF), IL-6, and Il.,-12 have all resulted in 
enhanced antibody and CTL responses for several antigens genes (Xiang and Ertl, 1995; 
Geissler et al, 1997; Iwasaki et a~ 1997a). Addition of sequences encoding costimulatory 
molectiles such as B7-2 and CD40L have also enhanced responses to DNA vaccines 
(Tsuji, et al 1997; Mendoza et al, 1997; Corr et al, 1997; Iwasaki et al, 1997a). 
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Intrinsic adjuvant m DNA vaccines . The performance of vaccines are often 
enhanced by the addition of adjuvants . DNA vaccines have an intrinsic adjuvant within 
the very sequences of the plasmid . These sequences are known as immunostimulatory 
sequences, or ISS (Yi et al 1996; Sonehara et al, 1996). These are palindromic hexamers 
with the motif of 5 ' -purine-purine- C-G-pyrimidine-pyrimidine-3' (Yamamoto et al, 
1992). They are found in higher frequency on bacterial DNA than in vertebrate DNA and 
are present in unmeth ylated form in bacteria l DNA but are frequentl y methylated in 
vertebrate DNA (Pisetsky , 1996). These sequences are mitogeni c for B cells and 
stimu late B cells to secrete the cytokines IL-6 and IL-12 (Klinman et al 1997), and to 
produce IgM (Yi et al, 1996) . These motifs can also stimulate natural killer (NK) cell 
activity and IFN-y secretion (Cowdery et al, 1996), as well as secretion ofIFN a/P, Il.,-12 
and TNF-cx. by activated macrophages that ingest these oligonucleotides (Ballas et al 
1996; Stacey et al, 1996). These cytokines induce IFN-y production, thus promoting the 
development of a Thl response (Swain et al, 1991). The presence ofISS in plasmids used 
for DNA immunization has been shown to enhance responses raised against P-
galacto sidase by i.d. immunization (Sato et al, 1996) and against malaria 
circumsporozoite prote in (Klinman et al, 1997). 
Specia l applications of DNA vaccine s. DNA immunization has also had 
promisin g results in certain difficult areas of vaccinology, which will not be discussed 
here . In animal models , DNA immunization has been successful in breakin g to lerance to 
chronic hepatitis (Mancini et al, 1996; Davis et al, 1997), resolution of persistent 
infection (Martins et al, 1995), neonatal immunization (Bot et al, 1997; Sarzotti et al, 
11 
1997), immunization in the presence of maternal antibody (Hassett et al, 1997; Manickan 
et al, 1997b; Martinez et al, 1997; Wang et al, 1997), control of allergic respon ses (Hsu et 
al, 1996), control of autoimmune disease (Waisman et al, 1996; Ramshaw et al, 1997), 
and raising antitumor responses (Syrengelas et al, 1996; Yang and Sun, 1995; 
Rakhmi levich et al 1996) . DNA vaccines have also been used to deliver multiple 
proteins , thus overcoming genetic restriction of some species to the single proteins 
(Doolan et al, 1996). The use of DNA vaccines encoding expression libraries ( or ELI -
expression library immunization) may allow protective antigens to be identified for little 
understood pathogens , and to immunize with complete, but not whole , pathogen s (Barry 
et al, 1995; Johnston and Barry , 1997). 
Attributes of the immune response raised by DNA immunization 
Protection . DNA immunization has been successfully used in animal mode ls for a 
variety of pathogens , including viruses (reviewed by Ramsay et al, 1997), bacteria 
(reviewed by Strugnell et al, 1997) and parasites (reviewed by Kal inna, 1997). Protect ion 
against viral infections have been achieved using DNA vaccines for influenza , human 
and simian immunodeficiency viruses, bovine and equine herpesviruses, papillomavirus , 
herpes simplex, hepatitis B, rabies, lymphochoriomeningitis, Newcastle disease, 
rotavirus, bovine viral diarrhea and murine cytomegalovirus. Protection against bacterial 
pathogens such as Mycobacteria tuberculosis, Borrelia burgdorjeri, Mycoplasma 
pulmonis and Clostridium tetani have been achieved with DNA vaccines . However , use 
of DNA vaccines for bacterial pathogens are complicated by the differences between 
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eukaryotic and prokaryotic transcription, translation and posttranslational processing. 
DNA vaccines have also raised protective responses against parasitic infections such as 
malaria, cryptosporidiosis, leishmaniasis, toxoplasmosis, and schistosomiasis. These 
protective responses have in general been correlated with high antibody and/or CTL 
responses, with a few exceptions, where protection was achieved despite low or no pre-
challenge antibody and/or CTL responses (Zarozinski et al, 1995; Martins et al, 1995; 
Strugnell et al, 1997; Fynan et al, 1993). 
Thl and Th2 responses raised by DNA vaccines. For many antigens, DNA 
immunization is able to raise both T-helper 1 (Thl) and T-helper 2 (Th2) types of 
responses, simply by delivering the DNA by gene gun and i.m. inoculations. A Thl 
response is favored by i.m. injection, whereas a Th2 response is favored by gene gun 
d;elivery of DNA. A Thl response promotes activation of macrophages and the delayed-
type hypersensitivity (DTH) reaction, and is better at controlling bacterial infections as 
well as chronic viral infections (Street and Mosmann, 1991). Thl clones are characterized 
by their secretion ofll,-2 and IFN-g and their promotion of IgG2a responses (Swain et al, 
1991). A Th2 response supports the development of an immune response that is 
especially adapted to activating nonphagocytic defenses and controlling parasitic and 
mucosa! infections (Street and Mosmann, 1991). Th2 clones characteristically secrete Il.,-
4, Il.,-5, Il,-6 and Il,-10 and promote lgGl , IgE and lgA responses (Swain et al, 1991). 
These two contrasting types of responses, however, can also have adverse effects 
on the host; Th2 responses are involved in allergic reactions (Street and Mosmann, 1991) 
while Thl responses may result in autoimmune disease (Fearon and Locksley, 1996). 
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Thus, the pre-determination of the type of T-helper response a specific DNA vaccine 
raises is crucial in developing the appropriate vaccine for a specific disease. Th l 
responses raised by DNA immunization have been used to control allergy (Hsu et al, 
1996), while Th2 responses have been used to prevent autoimmune diseases like 
experimental autoimmune ~ncephalomyelitis (Waisman et al, 1996; Ramshaw et al, 
1997). 
For influenza Hl , intramuscular immunization raises a Thl type of response while 
gene gun immunization raises a Th2 type of response (F eltquate et al, 1997). These Th 1 
and Th2 responses to i.m. and gene gun immunizations, respectively, have also been 
observed for other antigens such as influenza nucleoprotein (Pertmer et al, 1996), malaria 
circumsporozoite protein (Leitner et al, 1997), myelin basic protein (Ramshaw et al, 
1997) and measles hemagglutinin (Cardoso et al, 1998). Exceptions include the 
predominantly lgG2a response to gene gun immunization with measles nucleoprotein 
(Cardoso et al, 1998) and hepatitis C virus envelope E2 glycoprotein domains (Nakano et 
al, 1997), and the predominantly IgG 1 responses to i.m. immunization with secreted 
antigens such as ovalbumin (Boyle et al, 1997), secreted measles hemagglutinin (Kejian 
Yang, unpubli shed data), hepatitis B virus e antigen (Sallberg et al, 1997) and human 
growth hormone (Celia Torres, unpublished data). 
Mechani sm of Thl/Th2 induction by DNA vaccines. The mechanism behind the 
contrasting respon ses raised by the same DNA vaccine but delivered by different routes 
is still under investigation. There are some fundamental differences between gene gun 
and i.m. immunizati ons that may have profound effects on the nature of the immune 
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responses they elicit. One striking difference between these two methods is the amount of 
plasmid they deliver. Gene gun immunization uses sub-microgram amounts of plasmid 
DNA to raise maximal responses (Fynan et a~ 1993). In contrast, i.m. and i.d. 
immunization require 10- to 100-fold more DNA to elicit maximal responses (Robinson 
et al, 1997). Thus, in gene gun immunization, it is possible that the low dose of plasmid 
used as vaccine results in the introduction of few ISS into the animal, and thus elicits a 
Th2 response, as opposed to the Thl response elicited by the inoculation of high doses of 
plasmid by i.m. or i.d. immunizations (Barry and Johnston, 1997). However, results from 
David Feltquate (unpublished) suggest that DNA dose and CpG sequences may not be 
necessary for the Thl response elicited by i.m. immunization . 
Alternatively, the difference in efficiency of the two methods and the Th types of 
responses they elicit may be attributed to delivery of plasmid into cells as opposed to 
extracellularly. While the gene gun delivers DNA-coated gold beads directly into the 
cells at the target site (Tang et al, 1992), i.m. injections deliver DNA extracellularly 
(Wolff et al, 1992). In i.m. injections, some mechanism of DNA uptake by the transfected 
cells must occur, while in gene gun immunization, no such uptake is required. Such 
uptake of DNA by transfected cells may play a role in the effect of ISS on raised immune • 
responses (Feltquate et al, 1997). 
Another difference between these two methods is the immunological context of 
their target sites. The skin target site is specialized for immune surveillance, and contains 
a high frequency of bone marrow-derived APCs, the epidermal Langerhans cells (Stingl, 
1990). In contrast , the muscle has a relatively smaller number of a different type of APC, 
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macrophages (Hohlfeld and Engel, 1994). It is likely that this difference in 
immunological context and types of APCs between the two target sites influenc.es the 
nature of the immune response elicited. The effect of route of immunization on antibody 
responses has been demonstrated in other systems, with intraperitoneal, intravenous, 
intramuscular, and intranasal inoculations eliciting different antibody subclasses 
(Sangster et al, 1997; Hocart et al, 1989; Gahery-Segard et al, 1997; Morikawa et al, 
1992). 
Mechanism of initiation of immune responses by DNA immunization 
With the advent of the technology of DNA immunization, several dilemmas were 
raised with regard to the mechanism of initiation of immune responses by DNA 
immunization . One was the apparent contradiction by DNA immunization of the idea that 
by immunizing an animal with very low doses of protein, tolerance instead of immunity 
would arise (Mitchison, 1968; Zinkemagel et al, 1997). Only picogram to nanogram 
levels of protein are expressed following DNA immunization (Tang et al, 1992; Hartikka 
et al, 1996; Eisenbraun et al, 1993). Despite these low levels of antigen expression, DNA 
immunization raises potent immune responses. 
Another enigma in DNA immunization was that of antigen presentation. 
Typically, antigen presentation by professional antigen-presenting cells (APC) that are 
bone marrow-derived is required to initiate immune responses (Ni and O 'Neill, 1997). 
Professional APCs are positive for both l\1HC class I and l\1HC class II, and thus can 
initiate both CTL and antibody responses (Steinman et al, 1993). However, following 
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DNA immunization, most of the observable antigen expression is by the predominant 
somatic cell type at the site of inoculation or target site; i.e. keratinocytes after gene gun 
immunization (Raz et al, 1994; Andree et al, 1994) and muscle cells following i.m. 
immunization (Wolff et al, 1990). Unlike hemopoietic cells, these cells are not derived 
from the bone marrow. These cells express low levels of WiC class I on their surface 
and do not constitutively express WiC class II or costimulatory molecules (Hohlfeld and 
Engel, 1994; Chu et al, 1989). Antigen presentation by these nonhemopoietic cells has 
been shown to lead to tolerance (Warrens et al, 1994; Ga~parllet al, 1988). 
There are several models for the antigen presentation and antigen expression 
involved in initiation of immune responses by DNA immunization (Pardoll and 
Beckerleg, 1995; Figure 4). It was postulated during the nascent period of the technology 
of DNA vaccines that the transfected nonhemopoietic keratinocytes or muscle cells might 
be presenting as well as expressing the antigen to initiate immune responses (Figure 4A). 
It was postulated that DNA immunization somehow "activated" the.se nonhemopoietic 
· cells and turned them into effective antigen-presenting cells. 
In another model, bone marrow-derived APCs that are either trafficking through 
or resident at the target site somehow take up the DNA vaccine-expressed antigen from 
the nonhemopoietic cells at the target site (Figure 4B). In this scenario, the keratinocytes 
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Figure 4. Hypothetical models for the mechanism of initiation of immune responses by DNA 
immunization . See text for details. APC(s) - antigen-presenting cell(s) 
18 
antigen themselves. Instead, professional APCs present the antigen and initiate the 
immune response. 
Another model postulates that professional APCs at the target site are directly 
transfected with the DNA vaccine (Figure 4C). In this way, they would be expressing the 
antigen as well as presenting the antigen to initiate the immune responses. 
It would also be realistic to expect that a combination of these possibilities may be 
occurring in vivo. 
It was also unclear how DNA immunization with intracellular and membrane-
bound antigens such as influenza NP and influenza HI , respectively, are able to elicit the 
high-titer antibody responses observed for these antigens (Ulmer et al, 1993; Robinson et 
al, 1997). Antibody responses to exogenous proteins are elicited following uptake by 
professional APCs and subsequent MHC class II presentation of the antigen to CD4-
positive T cells which then provide help for antibody production by B cells (Morrison et 
al, 1986; Swain, 1983; Abbas, 1988). It can be expected that DNA-encoded secreted 
proteins would have easier access to such exogenous uptake than membrane-bound and 
~ritra.cellular proteins. In addition, a secreted antigen could be recognized and taken up by 
antigen-specific B cells via lg receptors (Hodgkin and Basten, 1995; Liu et al, 1994). A 
secreted antigen would also be more easily transported to lymphoid tissues , where 
immune responses are initiated (Zinkernagel et al, 1997). For these reasons , the influenza 
NP and HI proteins, being assumed to remain associated with the transfected cell and 
unable to circulate as soluble proteins, would be expected to be less effective than a 
secreted protein at raising antibody responses. 
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Objectives of this dissertation 
The objective of this dissertation was to address specific aspects of the 
mechani sm of initiation of the immune response elicited by DNA vacc ines. In particular, 
this dissertation addresses three problems : 1) the role of antigen expression at the target 
site; 2) the role of antigen presentation by bone marrow-derived cells; and 3) the effect 
of secretion of antigen on antibody responses . 
The role of antigen expression at the target site. To examine the role of antigen 
expression at the target site in the initiatio n of immune responses by DNA immunization, 
mice were immuni zed by gene gun or by i.m. injection, and the target sites were excised 
at various time point s post-immunization , or was left intact. The hypo thesi s being tested 
was that antigen expression at the target site wou ld be essent ial in initiating an immune 
response by DNA immunization . 
Results presente d in Chapter I demonstrate that antigen expression at the 
epidermal target site plays a cent ral role in raising an immune response by gene gun 
immunizati on, while antigen express ion at the muscle target site is nonessential in raising 
an immune response by i.m. immunizati on. For both gene gun and i.m. immunizati ons, 
the form of the DNA vaccine -enco ded antigen (intracellular, membrane-bound or 
secreted) did not influence the role of the target site. 
The role of antigen presentation by bone marrow-derived cells. To examine 
the role of ant igen presenta tion by bone marrow-derived cells in the initiation of immune 
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responses by DNA immunization, bone marrow chimeric mice were immunized by either 
gene gun or i.m. injection. The hypothesis being tested was that antigen presentation by 
bone marrow-derived cells, and not by nonhemopoietic cells, would initiate immune 
responses to DNA immunization. 
Results presented in Chapter II demonstrate that bone marrow-derived cells are 
the principal APCs that initiate the immune response to DNA immunization. 
Nonhemopoietic cells such as keratinocytes in the skin and muscle cells do not present 
antigen following gene gun and i.m. immunizations, respectively. 
Effect of secretion of antigen on antibody responses . To examine the effect of 
secretion of antigen on antibody responses raised by DNA immunization, mice were 
immunized with plasmids expressing either a secreted or a membrane-bound form of 
influenza Hl , by either gene gun or i.m. injection. The hypothesis being tested was that 
secretion of an antigen would lead to enhanced antibody responses. 
Results presented in Chapter III demonstrate that secretion of Hl does not 
enhance antibody responses to HI following both gene gun and i.m. immunizations. One 
remarkable difference observed between the antibody responses raised by secreted and 
membrane-bound HI is the predominant IgG subclass of the response following i.m. (but 
not gene gun) immunization. While secreted Hl raises predominantl y lgGl , membrane-
bound Hl raises predominantly IgG2a. 
MATERIAL AND METHODS 
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MATERIALS AND METHODS 
Cells: The monkey kidney cell line, COS-7, the murine mastocytoma cell line, 
P815, and the mouse T-lymphoma cell line, EL-4, were purchased from the American 
Type Culture Collection (ATCC, Rockville, MD). 
Bacteria: Competent bacteria used to amplify plasmid DNA were JMI 09 and 
HB 101 strains of Escherichia coli obtained from the UMass Nucleic Acids Facility 
(Worcester, MA). 
Virus: AIPR/8/34 (HlNl) virus was obtained from Dr. John Herrmann (UMass, 
Worcester MA) and grown in the allantoic cavity of IO-day old embryonated chicken 
eggs (SP AF AS, Preston, CT). AIPR/8/34 virus for coating ELISA plates was obtained 
from Dr . Robert Webster (St. Jude Children ' s Research Hospital, Memphis, Tennessee) 
. or from allantoic fluids enriched for virus by sucrose gradient centrifugation. 
Peptides: The H-2Db-restricted peptide NP366-374 (ASNENMETM) and the H-
2Kd-restricted peptide NP147-155 (TYQRTRALV) from the nucleoprotein of influenza 
AIPR/8/34 virus were commercially synthesized and purified (Alberta Peptide Institute, 
Edmonton, Alberta, Canada). 
Plasmids: Antigen-expressing plasmids used in this study include : 
pJW4303/Hl that expresses influenza A/PR/8/34 Hl (Robinson et al, 1995); pWRG1602 
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that expresses hGH, (Eisenbraun et al, 1993); and pCMV/NP that expresses influenza 
A/PR/8/34 NP (Iwasaki et al, 1997a). 
The plasmid expressing the wild-type, membrane-bound form of HI , pJW4303/Hl 
was modified to express a secreted form of HI. This plasmid expressing secreted HI, 
pJW4303/sHl, was constructed by substituting an EcoRI-BamHI polymerase chain reaction 
(PCR)-generated fragment for the endogenous EcoRI-Bamlil fragment of HI (Figure 1). 
Primers used for PCR were Pl (5' - CAAACAAGGTGAACTCTG-3', nt. 1210 to 1228, 
GenBank #102143; Winter et al, 1981) and P2 (3'-TTAGTTACCCCTAGATAGTCTAA 
at~cg-5', nt. 1600-1633). P2 introduced a stop codon (italicized) at the beginning of 
the transmembrane sequence (nt. 1620), followed by a BamHI recognition site (underlined). 
The PCR product was cut at an internal EcoRI site (nt. 1269) and at the BamJil site 
introduced by P2. Clones were sequenced using the Pl primer to confirm in-frame 
substitution of the stop codon. 
The plasmids pJW4303, pJW4303/Hl , pJW4303/sHI, and pWRG1602 were 
purified using Qiagen Giga kits (Qiagen, Chatsworth, CA). The plasmids pCMV and 
pCMV/NP were purified using Wizard Maxi Prep columns (Promega, Corp., Madison, 
WI). The absence of E. coli DNA or RNA was verified by determination of optical 
density (O.D.) at 260 nm and by agarose gel electrophoresis. Identity and integrity of 
purified plasmids was verified by digests with appropriate restriction enzymes and by 
agarose gel electrophoresis . Plasmids were resuspended in TE buffer (IO mM Tris-HCl, 
pH 8.0, I mM EDTA) and stored at - 20°C until use. 
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Animals: All procedures on mice were performed according to institutionally 
approved protocols . Six- to eight-week old female BALB/c mice were obtained from 
Taconic Farms (Germantown, NY) and used for all experiments except where noted. For 
the construction of bone marrow chimeras, female BALB/c, C57BL/6, DBA/2 and 
CB6Fl mice were obtained from Charles River Laboratories (St. Constant, Quebec, 
Canada). Female IL-4 knock-out mice in BALB/c background and age-matched BALB/c 
mice were obtained from Jackson Laboratories (Bar Harbor , l\ffi) . Mice were 
anesthetized with a 4: 1: 10 mixture of ketamine:xylazine:saline for immunizations and 
surgical procedures. 
Construction of bone marrow chimeras: Bone marrow chimeras were 
constructed by Akiko Iwasaki, in the laboratory of Dr. Brian Barber at the Department of 
Immunology , University of Toronto, Canada. Female (C57BL/6 x BALB/c)Fl mice were 
used as recipients. Female BALB/c (H-2~ or C57BL/6 (H-2b) mice used as donors were 
depleted of mature T cells by the injection of concentrated rat antibodies YTS 191 (anti-
CD4) and YTS 169 ( anti-CDS) (Cobbold et al, 1984) on day -3 and day -1 relative to 
bone marrow transfer . On day 0, bone marrow from femurs and tibia of donor mice was 
collected. Complete depletion of T cells in donor mice was confirmed by surface 
immunofluorescence staining cells from the mesenteric lymph nodes with phycoerythrin-
conjugated anti-CD4 and FITC-conjugated anti-CD8 (Becton Dickinson, San Jose, CA). 
Female recipient mice were irradiated at day O with 9.5 Gy and then reconstituted with 2 
x 107 T cell-depleted bone marrow cells from either C57BL/6 or BALB/c donors. 
25 
Reconstitution of bone marrow chimeric mice was verified by F ACS staining of 
peripheral blood cells from each recipient mouse with either an anti I-Ad monoclonal 
antibody (HB3, ATCC) or an anti I-Ab monoclonal antibody (HB183, ATCC), and 
secondary FITC-conju gated goat anti-mouse monoclonal antibody (Sigma). 
Transfection of COS-7 cells: Expression of the plasmids pJW4303/Hl and 
pJW430 3/sH1 was determined by transiently transfecting 105 COS-7 cells with 10 µg of 
plasmid DNA and electroporating at 0.25 V and 960 µF with a Bio-Rad Gene Pulser (Bio-
Rad, Melville, NY) . Control COS cells were transfected with pJW4303 vector . One hundred 
nanogram s of p WRG 1602 encoding human growth hormone (hGH) under the control of a 
CMV promoter was added to all transfections as internal control for transfection efficiency. 
Cells were allowed to grow to confluency in RPMI-1640 (GibcoBRL, Grand Island, NY) 
with 2 mM L-glutamine (GibcoBRL), 100 U/ml penicillin (GibcoBRL ), 100 µg/ml 
streptomycin (GibcoBRL ) and 5 % fetal calf serum (GibcoBRL ) for 72 hours at 37°C and 
· 5% CO2. Culture supematants were collected and cells were harvested with TEN buffer ( 40 
mM Tris-HCl pH 7.5, 1 mM ethylenediaminetetracetic acid (EDTA) , 150 mM NaCl) at 72 
hours post-transfection . Complete protease inhibitor cocktail tablets (Boehringer Mannheim, 
Indianapolis, IN) were added per manufacturer 's directions to culture supematants and cell 
lysates . Cells were collected by a five-minute centrifugation at 1500 rpm at 4°C. Cell pellets 
were then lysed with lysing buffer (50 mM Tris-HCl pH 7.5, 150 mM NaC l, 40 mM 
octylglucoside) for one hour at 4°C, followed by microcentrifugation at 1200 rpm for 15 
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minutes at 4°C to remove cell debris. Cell extracts and culture supernatants were kept at 
-70°C until ready for use. 
Antigen-capture ELISAs: Expression of HI and sHl was quantitated by an 
antigen-capture ELISA Ninety-six-well Easy Wash ELISA plates (Corning, Coming, NY) 
were coated with a 1:1000 dilution of a rabbit polyclonal HI-specifi c antiserum1 in 
carbonate buffer (15 mM Na2COJ, 35 mM NaHCOJ, pH 9.6), and incubated at 4°C 
overnight. After washing plates three times with 0.05% Tween-20 (Sigma, St. Louis, MO) 
in phosphate buffered saline (PBS~ Sigma) or PTw-20, plates were blocked with 3% dry 
milk in carbonate buffer for 1 hour at 37°C. Plates were washed three times, and cell extracts 
or culture supernatant s from transiently transfected COS cells diluted in 0.5% bovine serum 
albumin (BS~ Sigma) in PTw20 were added. A standard curve was generated using 
purified NPR/8 /34 (HlNl ) virus lysed for 5 minutes at room temperature in virus lysing 
buffer (0.05 M 'fris-HCI, pH 7.5, 0.5% Triton X-100, 0.6 M KCl) then diluted in sample 
dilution buffer. Plates were incubated for 2 hours at 37°C, then washed three times with 
PBS-Tw2 0. A I : 1000 dilution of a polyclonal mouse HI- specific antiserum2 was added, and 
plates were incubated for I hour at 37°C. Plates were then washed three times with 0.1% 
Triton-X (Sigma) in PBS (PTx), with the second wash being allowed to stand for l hour at 
37°C. After the third wash, a 1 :4000 dilution of peroxidase-conjugated goat anti-mouse IgG 
(heavy and light chain-specific , Southern Biotechnology, Birmingham , AL) was added and 
plates were incubated for I hour at 37°C. Plates were then washed three times with PTx, 
1Serum from a rabbit immunized by gene gun three times with 30 µg pJW4303/Hl. 
2 A pool of mouse sera from six mice immunized by gene gun three times with 0.04 µg pJW4303/Hl. 
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with the second wash being allowed to stand for 1 hour at 37°C. After the third wash, 
peroxidase substrate (Sigma) was added (0.20 mM ABTS, 0.05 M citrate, pH 4.0, 0.02% 
H202) and color development was allowed to proceed for 30 minutes . Reactions were 
stopped with SDS at a final concentration of 1 %, and absorbance was read at 405 run using 
an Emax precision microplate reader (Molecular Devices , Sunnyvale, CA). Data was 
analyzed using the Softmax program (Molecular Devices). Amounts of HA expression 
represented as HA units were calculated by interpolating points within the standard curve of 
lysed A/PR/8/34, which was assumed to have 3 5% of its total protein content as units of HA 
(Katz and Webster, 1989). 
The expression of human growth hormone in culture supematants and cell lysates 
from transfected COS-7 cells, or in homogenized mouse skin target sites ( described 
below) , was determined using an ELISA kit (Boehringer Mannheim , Ind ianapolis, IN) . 
This assay was not sufficiently sensitive to determine hGH expression in muscle biopsies . 
Preparation of plasmid DNA-coated gold beads for gene gun immunization: 
For examining the role of antigen expression at the target site in DNA immunizations, 
plasmid DNA were precipitated onto 2.6 micron gold beads (PowderJect Vaccines, Inc., 
Madison, WI), at 2 µg plasmid DNA per milligram gold. One hundred microliters of SO mM 
spermidine was added to the appropriate weight of gold beads and mixed by sonication. 
Appropriate volumes of plasmid DNA in TE buffer was added and the gold suspension was 
mixed by briefly vortexing at low speeds. Two hundred microliters of 1 M CaCh was then 
added drop by drop, while vortexing at very low speed. The suspension was then allowed to 
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settle for 10 minutes at room temperature before washing in absolute ethanol three times by 
microcentrifugation for 15 seconds and discarding the supernatant. The DNA-coated gold 
beads were then resuspended in cold absolute ethanol, using 7 milliliters of ethanol per 
milligram gold. 
To examine the role of antigen presentation by bone marrow-derived cells and the 
effect of DNA immunization with a secreted form of influenza HI on antibody responses 
to HI , plasmid DNA was precipitated as described above, with the following 
modifications : 1 micron gold beads (Bio-Rad, Melville, NY) were coated with 0.25 µg 
plasmid DNA per milligram of gold, using 100 mM spermidine and 2.5 M CaC}i. 
To prepare gold beads used for immunization at different doses, gold beads 
coated with experimental DNA were diluted with gold beads coated with control DNA to 
give doses of 0.4 µg, 0.04 µg and 0.004 µg experimental DNA with 0 µg, 0.36 µg and 
0.396 µg of control vector DNA, respectively, per immunization . This was done in order 
to give the same number of gold beads and the same amount of DNA coated per bead for 
all immunizing doses . 
Preparation of tube shots for gene gun immunization: Shots were prepared 
by aspirating sonicated suspensions of DNA-coated gold beads in ethanol using a •l O ml 
syringe into a 16-inch long Tefzel tubing (McMaster-Carr, Chicago, IL), with inner diameter 
of 0.93 inches and outer diameter of 1/8 inch. The tube was then placed in a rotating sleeve 
(PowderJect Vaccines, Inc.). The gold beads were allowed to settle for five minutes. The 
sleeve was then rotated at 20 rpm for 5 minutes, to coat the inner surface of the tubing with 
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the gold beads. Nitrogen gas from an attached tank was then allowed to enter the rotating 
sleeve at a flow rate of around 1. 8 liters per minute with continuous rotation of the sleeve, to 
evacuate the ethanol and precipitate the gold beads onto the tubing. Evacuation was done for 
around 5 minutes, or until the gold beads were completely dry, as indicated by the 
transformation of the appearance of the gold beads from dull brown to shiny yellow. The 
tubing was then removed from the sleeve and ends that were irregularly coated with gold 
beads were cut and discarded. The remainder of the tubing was cut into shots 0.5 inches 
long, with each shot having 0.5 mg of the DNA-coated gold beads. Shots were placed in a 
glass scintillation vial with · a desiccant pillow, and kept at 4°C until use, for no longer than 
two weeks. 
DNA immunization by gene gun: A hand-held helium-pul sed Accell® gene 
gun (PowderJect Vaccines, Inc.) was used to deliver shots of 0.5 mg of 1 micron gold 
beads per shot, at a pressure of 400 to 450 psi, onto the fully shaved abdominal skin of 
anesthetized mice. To examine the effect of secretion of HI on antibod y responses, three 
shots were delivered with a total of 0.4 µg, 0.04 µg or 0.004 µg of the experimental 
DNA to each mouse. Secondary immunizations were performed similarly. 
For co-immunization of sHl with HI , gold beads were coated separately with 
pJW4303/sH1 or pJW4303/Hl and diluted with control DNA-coated gold beads, then 
combined to give a total of 0.04 µg experimental DNA per immunization . 
For examining the role of antigen expression at the target site, mice were 
immunized by gene gun as described below. 
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DNA immunization by i.m.: To examine the effect of secretion of HI on 
antibody respon ses, mice were immunized i.m. by surgically exposing the quadriceps by 
making a smaIJ lateral incision on both hind legs of the mouse. A total volume of 50 µI of 
plasmid DNA diluted in normal saline at three concentrations (1 µg/µl, 0.1 µg/µl, 0.01 
µg/µl) were delivered to the quadriceps of each hind leg to give three differ ent 
imi:n-unizing doses per mouse (100 µg , 1 0 µg , 1 µg) . 
For examining the role of antigen expression at the target site, nuce were 
immunized i.m. as described below. 
Surgical excision of immunization target sites: Surgical exc1s1ons were 
performed according to protocols approved by the Institutional Animal Care and Use 
Committee. For gene gun immunizations , four non-overlapping shots of 1 µg DNA per shot 
were delivered onto marked target areas on the shaved dorsal skin of anesthetized mice 
. through a 6-mm-diameter opening in a parafilm/aluminum foil template . At various times 
following immunization, target area s were excised using an 8-mm biopsy punch (Acuderm, 
Fort Lauderdale , FL), and the wounds sutured. Total excision of the target site was 
monitored in preliminary experiment s by testing for hGH expression in biopsies of skin 
surrounding the target sites at 24 hours post-immunization using the hGH antigen capture 
ELISA kit (Boehringe r Mannheim, Indianapolis , IN) described above . 
To quantitate hGH expression in skin, skin biopsies were homogeniz ed in 2 ml of 
0.5% Triton-X-100 in PBS with lx complete protease inhibitor tablet s (Boehringer 
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Mannheim) using a Polytron homogenizer (Tekmar, Cincinnati, OH). Homogenates 
were clarified by microcentrifugation, then supernatants were stored at - 70°C until 
assayed. 
For i.m. immunizations, 100 µg of plasmid DNA was injected in 50 µl of normal 
saline using a 28-gauge needle, into the surgically exposed straight femoral muscle of the 
left hind leg. The straight femoral muscle was excised at various time points following 
injection by teasing the muscle bundle from adjacent muscle bundles with sharp curved 
forceps. The muscle bundle was then excised using scissors by cutting at the muscle 
origin and insertion sites, taking care to maintain the integrity of the epimysium 
encompassing the straight femoral muscle. Wounds were sutured after surgery, and the 
mice were monitored for infection and mobility problems for two weeks following 
surgery. 
Total excision of the injected muscle bundle was verified in preliminary 
experiments by visually monitoring leakage of co-injected 0.004% trypan blue. To 
determine whether any possible leakage of DNA during excision of the injected muscle 
can result in antibody responses, the straight femoral muscle was excised from nai'.ve 
mice and 50 µg pWRG1602 in 50 µl saline was "injected extramuscularly'' (e.m.) into the 
space where the straight femoral muscle was located. Mice were also injected with an 
equivalent amount or with 100 µg of pWRG1602 into the straight femoral muscle (i.m.) 
as positive controls. 
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To control for inflammatory responses due to surgery, the straight femoral muscle 
was surgically exposed and tea sed from adjacent muscles upon injection in intact controls 
to closely mimic the surgery performed on mice that had the ir target sites excised. 
Serum antibody determination by ELISA: Mice were bled from the tail vein 
prior to immunization (pre-immune sera), and at two- to four-week intervals post-
immuniz ation. Sera were collected individually then stored at -20°C. For pooled samples, 
equal aliquots from individual sera were combined. Ninety-six-well Easy Wash ELISA 
plates (Corning) were coated with 200 HAU of A/PR/8/34 (HlNl) influenza virus or 4 
µglml purified hGH (Sigma) in carbonate buffer and incubated overnight at 4°C. Plates were 
then washed with PTw-20 , and 3-fold dilutions oftest sera (individual or pooled), starting at 
1: 100, were added . Purified mouse immunogl obulin (Southern Biotechnology , Birmingha m, 
AL) of the specific isotype being determined was captured with anti-mouse lg (heavy and 
light chain-specific, Southern Biote chnology) to generate a standard curve. Plates were 
incubated at 3 7°C for 2 hours, then washed three times. Influenza-specific IgG was detected 
with a 1 :4000 dilution of peroxidase-conj ugated anti-mouse antibody (Southern 
Biotechno logy) specific to the immuno globulin isotype being measured and incubated at 
37°C for 1 hour . Plates were then washed, and peroxidase substrate (0.20 mM ABTS, 0.05 
M citrate, 0.02% H20i) was added . Color development was allowed to proceed for 30 
minutes , before adding SDS to a final concentration of 1 % to stop the reaction . Absorbance 
of samples was read at 405 run with an Emax precision microplate reader (Molecular 
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Devices , Sunnyvale, CA). Data was analyzed usmg Softmax (Molecular Devices, 
Sunnyvale, CA). 
Determination of relative affinities by ELISA: Relative affinities were 
determined by ELISA using thiocyanate elution (MacDonald et al, 1988; Pullen et al, 
1986). ELISAs were performed similar to serum antibody determination ELISAs up to 
the addition of samples and standards . · Samples were diluted to give similar 
concentrations of lgG and optical densities near the top of the linear part of the titration 
curve (as predetermined in serum antibody ELISAs). After incubation of samples and 
standards , plates were washed three times with PTw-20. Different concentrations of a 
chaotropic agent, sodium thiocyanate (NaSCN ; Sigma), diluted in PBS were then added 
(no NaSCN, 0.5 M, 0 .75 M, 1 M, 1.5 M, 2 Mand 2.5 MNaSCN) . Plate s were allowed to 
stand at room temperature for 15 minutes, then washed six times with PTw-20. 
Subsequent steps were performed as in the serum antibody determ inat ion ELISAs . The 
concentration of lgG of each sample that was bound in the presence of NaSCN was 
divided by the concentration of IgG bound in the absence of NaSCN and expressed as 
percentages of initial IgG bound . Data were plotted as log10 of the percentage of initial 
lgG bound against the concentration of NaSCN. Third degree polynomial regression 
analysis was performed by Sigma Plot 4 .0 software (Chicago, IL). A line parallel to the x-
axis was drawn aty = 1.699 (log10 of 50% of initial lgG bound). The points relative to the 
x-axis where this line intersects the curve for a particular sample represents the affinity 
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index, or the concentration of NaSCN required to elute 50% of the specific IgG in the 
sample. 
CTL lysis assay: CTL assays were performed by Akiko Iwasaki in the 
laboratory of Dr. Brian Barber at the Department of Immunology, University of Toronto, 
Ontario, Canada. Target cells were labeled with 100 µCi of Na51Cr04 by incubating for 1 
hour at 37°C. Fl stimulator splenocytes were irradiated and pulsed with 0.1 µg/µl peptide 
for 1 hour. P815 target cells were pulsed with NP(l47-155) , while EL-4 target cells were 
pulsed with NP(366-374) . Effector spleen cells from individual spleens or pools of two 
spleens were harvested from immunized mice. Five x 106 splenocytes/ml were cultured in 
the presence of 2. 5 x 106 F 1 stimulator splenocytes per ml for 7 days in RPMI- 1640 with 
10% fetal calf serum (Immunocorp , Montreal, Quebec, Canada), 100 U/ml penicillin, 100 
µg/ml streptomycin and 2 mM L-glutamine . Target cells at 104 cells per well in triplicate 
were incubated for 4 hours at 37°C with serial dilutions of effector cells. Plates were briefly 
centrifuged and 25 µl of culture supernatant was taken for scintillation counting . Chromium 
release was measured using a TopCount scintillation counter (Canberra-Packard, Canada). 
Maximum release was determined from samples that contained 2% Triton X-100 alone. 
Spontaneous release was determined from samples that contained medium alone. Specific 
lysis was calculated as (experimental release - spontaneous release) / (maximum release -
spontaneous release) x 100%. 
Statistical Analysis: The Mann-Whitne y test (Daniel, 1987) was used to analyze 
differences between data, at a level of significance a = 0.05. 
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The most frequently transfected cells following DNA immunization are the cells 
that comprise the predominant cell type at the target site of immunization. Epidermal 
keratinocytes are the predominant transfected cells following gene gun immunizat ion 
(Raz et a~ 1994; Andree et al, 1994), while muscle ce11s are the predominant transfected 
cells following i.m. immunization (Wolff et al, 1990). Antigen expression in the skin 
target site is transitory , with expression being lost in about a week, as the epidermis 
sloughs off (Johnston and Tang, 1994) . In contrast, antigen expression can persist in the 
muscle from several weeks to a year and a half (Wolff et al, 1992). The skin target site 
can be considered an immunological organ (Stingl, 1990), while the muscle is not 
(Hohlfeld and Engel, 1994). Despite these differences between skin and muscle, both 
gene gun and i. m. immunizations are able to elicit long-term antibody responses 
(Robinson et al, 1995; Raz et al, 1994) . 
In this chapter , we address the role of antigen expression at the skin and muscle 
target sites in the initiation of antibody and CTL responses by gene gun and i.m. 
immunization. 
3 The data presented in this chapter have been published by Torres et al, 1997. 
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Role of antigen expression at the skin target site in initiation of immune responses 
by gene gun immunization 
Effect of excision of skin target site on antibody responses raised by gene gun 
immunization . Antigen expression at the skin target site played a central role in initiating 
immune responses in mice following gene gun immunization. Mice were immunized by 
gene gun, and their target sites excised at different time points, from 1 minute to 3 days 
post-immunization, or left intact. Antigen-specific serum antibody responses of 
individual mice were measured by ELISA at 12 weeks post-immunization (Figure 5). 
Initiation of maximal antibody responses to influenza H I was dependent on the 
skin target sites being left intact for more than three days (Figure 6). Excision of the skin 
target site within 24 hours severely limited the antibody responses raised against Hl . 
Only 9 of the 25 mice immunized had detectable antibody responses. The levels of these 
responses were less than 3% of the level of the response observed in mice with intact 
target sites. Excision of the target sites at three days following immunization resulted in 
detectable responses in 5 of the 5 mice tested, with the level of their responses being 
about 33% of the level seen in mice with intact target sites. Pre-immune sera and sera 
from mice immunized with control plasmid had no detectable antigen-specific antibodies. 
These results indicate that the presence of the skin target site is necessary in 
raising maximal antibody responses to a membrane-bound form of antigen such as 
influenza H l. 
At 
A B C 
Figure 5. Schematic for gene gun immunization and surgical excision protocol. Mice were immunized at four target sites on their dorsal skin through a 
parafilm/aluminum foil template, using the gene gun (A). After desired time (At) had elapsed, all four target sites were surgically excised using a biopsy 
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Figure 6. Antibody responses to gene gun immunization with pJW4303/Hl following excision of target 
sites. Mice were immunized with HI by gene gun and target sites were surgically excised at the 
indicated times. Sera were collected at 12 weeks post-immunization and specific IgG were determined 
by ELISA. The nwnber of mice with detectable specific lgG within each group is given as 
responders/total. Data are means± SEM of specific IgG for responder mice. Similar results were 
obtained in two independent experiments (data not shown). 
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Similar to the results seen for membrane-bound Hl, the antibody response to 
th(? intracellular antigen, influenza NP, was also dependent on the presence of the skin 
target site (Figure 7). Excision of the target site within 24 hours of immunization resulted 
in only 2 of 5 mice tested having detectable antibody responses. The level of their 
responses were only I2% of the responses seen in mice with intact target sites. As in HI-
immunized mice, leaving the target site longer, for three days, resulted in higher antibody 
responses, with the level of responses being 44% of the responses seen in mice with 
intact target sites. However, unlike for HI, leaving the target site intact for three days did 
not increase the number of responding mice, with only 2 of 6 mice tested having 
detectable antibody responses. Pre-immune sera and sera from mice immunized with 
control plasmid had no detectable antigen-specific antibodies. 
Therefore, similar to membrane-bound HI , antibody responses to the intracellular 
(and hence also cell-associated) antigen, NP, were dependent on the skin target site. 
Antibody responses to a secreted antigen, hGH, were also dependent on the skin 
target site (Figure 8). Excision of skin target sites within 24 hours of immunization 
resulted in only IO of 18 mice tested having detectable responses, with these responses 
f 
being only I 9% of the levels observed for mice that had intact target sites . Pre-immune 
sera had no detectable antigen-specific antibodies. Therefore, antibody responses to a 
membrane-bound, an intracellular and a secreted antigen were all dependent on the skin 
target site following gene gun immunization. 
Time course of antigen expression at the skin target site. The temporal 
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Figure 7. Antibody responses to gene gun immunization with pCMV/NP following excision of target 
sites. Mice were immunized with NP by gene gun and target sites were surgically excised at the 
indicated times. Sera were collected at 12 weeks post-immunization and specific IgG were detennined 
by ELISA. The number of mice with detectable specific lgG within each group is given as 
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Figure 8. Antibody responses to gene gun immunization with pWRG1602 following excision of target 
sites. Mice were immunized with hGH by gene gun and target sites were surgically excised at the 
indicated times. Sera were collected at 12 weeks post-immunization and specific IgG were determined 
by ELISA. The number of mice with detectable specific IgG within each group is given as 
responders/total. Data are means ± SEM of specific IgG for responder mice. Similar results were 
obtained in two independent experiments (data not shown). 
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with the time course of antigen expression in the skin. Expression of DNA vaccine-
encoded human growth honnone as measured by antigen-capture ELISA was not 
detectable at 8 hours post-immunization, peaked at 24 hours (approximately 15 ng/target 
site) then diminished to barely detectable levels (approximately 2 ng/target site) over a 72 
hour period (Figure 9). This time course is consistent with the nonnal sloughing of the 
mouse epidermis, resulting in the shedding of antigen-expressing keratinocytes (Johnston 
and Tang, 1994). 
Effect of excision of the skin target site on CTL responses raised by gene gun 
immunization. The CTL response to influenza NP demonstrated the same target site 
dependence as the antibody response to NP following gene gun immunization (Figure 
10). CTL responses of responder cells from pools of two spleens were assayed by 
chromium release at 6 weeks post-immunization4 . Maximal CTL responses were 
observed in mice that had their skin target sites intact for more than three days. Mice that 
had their target sites excised witltin 24 hours of'immunization did not have specific CTL 
activity, with their CTL responses being indistinguishable from the responses in mice 
receiving the control plasmid pCMV (<20% CTL lysis). In two out of three experiments, 
CTL lysis above 20% were observed for mice that had their target sites excised at three 
days following injection (data not shown). 
4 CIL assays were perfonned by Akiko Iwasaki at the University of Toronto. 
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Figure 9. Time course ofhGH expre$ion at the skin target site following gene gun immunization. Mice 
were immunized with pWRG1602 by gene gun and target sites were surgically excised at the indicated 
times. Expression of hGH at the target site was determined by antigen-capture ELISA . Data are 
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Figure 10. CTL responses to gene gun immunization with pCMV /NP following excision of target sites. 
Mice were immuniz.ed with NP or control vector by gene gun and target sites were either left intact or 
excised at the indicated times . CTL assays were done at 6 weeks post-immuniza tion . Control assays 
with unpulsed targets showed no detectable lysis (data not shown). Data are for three pools of two 
spleens each and are represented as the mean ± SEM. Similar results were obtained in three independent 
experiments (data not shown). 
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Role of antigen expression at the muscle ta.rget site in initiation of immune 
responses by i.m. immunization 
Effect of excision of muscle target site on antibody responses raised by i. m. 
immunization . In contrast to the role of antigen expression at the skin target site, antigen 
expression at the muscle target site played no role in initiating immune responses in mice 
following i.m. immunization. Mice were immunized i.m. in their straight femoral 
muscles. The injected muscle was surgically excised within 1 minute, at 10 minutes, and 
4 hours post-immunization, or left intact. Antibody responses were measured as in gene 
gun-immunized mice (Figure 11 ). 
' Excision of the muscle target site within one minute, at 10 minutes or 4 hours 
post-injection resulted in maximal antibody responses in all the mice immunized with the 
membrane-bound antigen, Hl (Figure 12). These responses were not due to nonspecific 
inflammatory responses arising from surgery, since these responses were antigen-
specific, and no responses were observed in unirnmunized mice that underwent mock 
surgery (data not shown). Pre-immune sera as well as sera from mice immunized with 
control plasmids had no detectable antigen-specific antibodies. 
Excision of the muscle target site at 10 minutes post-injection resulted in maximal 
responses in all mice immunized with the intracellular antigen, NP (Figure 13). Similarly, 
excision of the muscle target site within one minute, at 10 minutes or 4 hours post-
injection resulted in maximal antibody responses, in all the mice immunized with the 
secreted antigen hGH (Figure 14). Pre-immune sera as well as sera from mice immunized 











Figure 11. Schematic for i.m. immunization and surgical excision protocol. Mice were immunized by i.m. injection in the straight femoral muscle of the 
left hind leg (A). After desired time (6t) had elapsed, the injected muscle was surgically excised (B) and the wound sutured (C). Sera were collected at 
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Figure 12. Antibody responses to i.m. immunization with pJW4303/H l following excision of target 
sites. Mice were immwlized with HI by i.m. injection and target sites were surgically excised at the 
indicated times . Sera were collected at 12 weeks post-immunization and specific IgG were determined 
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by ELISA. The number of mice with detectable specific IgG within each group is given as responders/total . 
Data are means ± SEM of specific IgG of responder mice. Similar results were obtained in two 
independent experiments (data not shown). 
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Figure p . Antibody responses to i.m. immunization with pCMV/NP following excision of target 
sites. Mice were immuniz.ed with NP by i.m . injection and target sites were surgically excised at the 
indicated times. Sera were collected at 12 weeks post-immunization and specific lgG were detennined 
by ELISA. The number of mice with detectable specific IgG within each group is given as 
responders/total. Data are means± SEM of specific lgG for responder mice. 
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Figure 14. Antibody responses to i.m. immunization with pWR.Gl602 following excision of target 
sites. Mice were immunized with hGH by i.m. injection and target sites were surgically excised at the 
indicated times. Sera were collected at 12 weeks post-immunization and specific IgG were determined 
by ELISA. The nwnber of mice with detectable specific lgG within each group is given as 
responders/total. Data are means ± SEM of specific IgG fur responder mice. Similar results were 
obtained in two independent experiments (data not shown). 
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Effect of excision of muscle target site on longevity of antibody responses raised 
by i.m. immunization . Excision of the target site did not affect the longevity of antibody 
responses to membrane-bound Hl or secreted hGH, with maximal responses being 
maintained for up to 10 months (Figures 15 and 16). Therefore, prolonged antigen 
expression at the muscle target site is not necessary in raising long-lasting antibody 
responses . This is consistent with the observation that long-lasting antibody responses 
can be raised by gene gun immunization (Robinson et al, 1997), despite loss of antigen 
expression at the skin target site due to normal sloughing of the epidermis within two 
weeks . In addition, as in gene gun immunization, the form of antigen did not influence 
the role of antigen expression at the muscle target site following i.m. immunization . 
. Effect of excision of muscle target sites on CTL responses raised by 1.m. 
immunization . The CTL response to influenza NP demonstrated the same target site 
independence as the antibody response to NP following i.m. immunization (Figure 17). 
CTL responses were measured as in gene gun-immunized mice . Mice that had their target 
sites excised 10 minutes after injection had comparable CTL lysis as mice that had their 
target sites left intact. Mice immunized with control vector had baseline CTL lysis (<10% 
lysis). 
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Figure 15. Longevity of antibody responses to pJW4303/Hl raised by im . immuniz.ation. Mice 
were immunized with Hl i.m., and the target sites were either left intact (A) or excised at 10 min. 
post-immuniz.ation (B). Sera were collected at the indicated times. Specific IgG were determined 
by ELISA. Individual symbols represent individual mice. Pre-immune sera and sera from mice 
immunized with control vector alone had no detectable specific lgG (data not shown). 
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Figure 16. Longevity of antibody responses to pWRG1602/hGH raised by i.m. immunization. Mice 
were immunized with hGH i.m., and the target sites were either left intact (A) or excised at 10 min . 
post-immunization (B). Sera were collected at the indicated tim es. Specific IgG were determined 
by ELISA. Individual symbols represent individual mice. Pre -immun e sera had no detectable 
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Figure 17. CTI, responses to i.m. immunization with pCMV/NP following excision of target sites. Mice 
were immunized with NP or control vector by i.m. injection and target sites were either left intact or 
excised at 10 minutes post-injection. CTI, assays were done at 6 weeks post-immunization . Control 
assays with unpulsed targets showed no detect.able lysis (data not shown). Data are for three pools 
of two spleens each and are represented as the mean ± SEM. Similar results were obtained in three 
independent experiments (data not shown). 
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We believe that the target site independence of the antibody and CTL responses 
following i.m. immunization is not due to either incomplete ablation of the injected 
straight femoral muscle, or to leakage of the injected plasmid DNA outside the injected 
muscle, either during injection or surgical excision, for the following reasons: trypan blue 
injected into the straight femoral muscle can easily be seen to be contained within the 
muscle bundle, with no dye in the adjacent muscles (Figure 18B); trypan blue remains 
' . 
within the injected straight femoral muscle and does not leak into adjacent muscles 
during excision; the straight femoral muscle is encompassed by an epimysium that keeps 
that muscle discrete and separate from adjacent muscles and that supports the buildup of 
hydrostatic pressure resulting from injection (Davis et al, 1994); and the straight femoral 
muscle can be precisely and completely excised due to easily identified origin and 
insertion sites (Figure 18C). We also observed maximal antibody responses in all mice 
that had their injected muscles excised, in two independent experiments, for two different 
antigens, HI and hGH, and in one experiment for NP. We also demonstrated that even if 
50 micrograms of plasmid DNA (half the -amount of injected DNA) were to leak from the 
injected. muscle into inter-tissue spaces during surgical excision, such delivery of plasmid 
DNA outside the context of muscle tissue, i.e. extramuscularly, would not result in the 
initiation of substantial immune responses (Figure 19). 
A B C 
Figure 18. Photographs of injected straight femoral muscle. The straight femoral muscle is indicated by an arrow (A). and can be distinguished from the 
quadriceps muscle. Upon injection of dye, the dye is contained within the injected straight femoral muscle (B). l11e injected muscle is easily separated 





Figure 19. Extramuscular immunization with pWRG1602/hGH. Mice were immunized with hGH at the 
indicated doses either intramuscularly (i.m.) into the straight femoral muscle or following excision of 
straight femoral muscle, extra-muscularly (e.m.), into the space where the straight femoral muscle was 
located prior to excision. Sera were collected at 12 weeks post-immunization. Specific IgG were 
determined by ELISA. Pre-immune sera had no detectable specific IgG (data not shown). 
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Discussion 
In summary, we found that antigen expression at the skin target site was necessary 
for initiation of maximal antibody and CTL responses following gene gun immunization. 
In contrast, antigen expression at the muscle target site following i.m. immunization was 
not required for the initiation of maximal antibody and CTL responses . The role of the 
skin and muscle target sites in initiation of immune responses was not influenced by the 
form of the expressed antigen (membrane-bound, intrace llular or secreted) . Antigen 
expression at the target site was not necessary for maintaining the longevity of the 
antibody response to either secreted or membrane-bound antigens. 
Role of autiien expression at the skin tariet site. The differential dependence of 
DNA-raised immune responses on skin and muscle target sites may reflect the 
fundamental differences between these two sites. The skin is an animal ' s natural barrier 
against its environment. As such, it is immunologically active and is sometimes referred 
to as the SIS, or skin immune system (Bos and Kapsenberg, 1993). The skin has evolved 
an efficient system of immune surveillance, with bone marrow-derived epidermal 
Langerhans cells constituting approximately 3-4% of the cells in the epidermis (Stingl, 
1990). Langerhans cells initiate immune responses by taking up foreign antigens they 
encounter in the skin, then migrating to the draining lymph nodes where they present the 
foreign antigen (Moll et al, 1993). Langerhans cells migrate rapidly away from the site of 
antigen encounter. In contact hypersensitivity models, antigen-bearing Langerhans cells 
can be found in the draining lymph node within 6 to 24 hours after encountering antigen 
(van Wilsem et al, 1994~ Dandie et al, 1994). 
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The nonhemopoietic cells of the skin, the keratinocytes , are the predominant cell 
type observed to be transfected with DNA following gene gun immunization (Raz et al, 
1884; Andree et al, 1994). Keratinocytes may also play an important role in immune 
surveillance. Keratinocytes are specialized for enhancing the function of the Langerhans 
cells. Keratinocytes can secrete cytoki nes such as GM-CSF , IL- 1 and TNF-a in response 
to injury or upon encounter with a microbe (Bos and Kapsenberg , 1993). These cytokines 
act on Langerhans cells by upregulating the expression of MHC class II and adhesion 
molecules on the surface of Langerhans cells (McKenzie and Sauder, 1990). These 
cytokines also stimulate the migration of La~gerhans cells to the lymph node (Sting!, 
1990). In addition, keratinocytes secrete IL-I and IL-6 , which induce T cell proliferation 
and B cell growth and differentiation, respectively (McKenzie and Sauder, 1990). 
Kerat inocytes also secrete IL-8 , which, with IL-1, can promote T-cell migration to the 
epidermis (Barker et al, 1991). 
There is evidence that dendritic cells in the skin, presumably Langerhans cells, are 
directly transfected during DNA immunization . Antigen-expressing dendritic cells of 
cutaneous origin have been found in the draining lymph node of the skin within 24 hours 
of gene gun immunization (Condon et al, 1996). In addition, dendriti c cells from the skin 
have been shown to be transfected with plasmid DNA, as well as presenting the DNA-
expressed antigen to T cells, follow ing i.d. immunization (Casares et al, 1997). 
Despite the likely tran sfect ion of Langerhans cells by DNA immunization, we 
found that excision of the target site within one day post-immunization resulted in low-
level responses in only some of the immunized mice. The dependence of maximal 
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antibody and C1L responses on the skin target site appeared to correlate with the time 
course of antigen expression in the skin . Therefore , the transfected dendritic cells that 
migrate out of the target site to the lymph nodes within 24 hours post-immunization may 
not be sufficient to raise maximal antibody and CTL responses . This implies that antigen 
expression by nonmigratory cells , presumably keratinocytes, at the target site is necessary 
in raising maximal responses. 
Alternatively, only a fraction of the transfected Langerhans cells in the epidermis 
may migrate out of the target site within one day, and this fraction may be insufficient to 
raise maximal responses . The transfected Langerhans cells found in the lymph nodes 
within 24 hours-of gene gun immunization (Condon et al, 1996) may reflec t the fraction 
of Langerhans cells that are constitutively trafficking to the lymph node from the skin in 
the absence of antigenic stimulation (Dandie et al, 1994). It is possible that the bulk of 
directly transfected Langerhans cells leave the target site after three days . Three to five 
days have been shown to be the times when peak Langerhans cell migration occurs for 
complex antigens that require processing (Dandie et al, 1994; Woods et al, 1995). 
Low levels of responses were observed in a few of the immunized mice that had 
their target sites excised less than a day post-immunization. This suggest s that transfected 
dendritic cells that migrate into the draining lymph node before excision of the target site 
are able to initiate antibody responses in the absence of maximal antigen expression by 
keratinocytes , which occurs at 24 hours post-immunization . An alternative explanation 
would be that , in some mice , less than 24 hours may have been sufficient for uptake by 
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Langerhans cells of antigen expressed by keratinocytes at the target site to raise low level 
responses. 
The requirement for antigen expression by keratinocytes for initiation of maximal 
responses following gene gun immunization is supported by a recent study (Klinman et 
al, 1998). The authors performed target site excisions at different time points post-
immunization then grafted the target sites onto naive recipient mice . DNA expressing 
malaria circumsporozoite protein (CSP) was used. The authors studied both primary and 
secondary responses. They found that excision of target sites in donor mice within 5 
hours up to 3 days following gene gun immunization resulted in low-level or no primary 
responses. Specifically, they observed lower lgG levels and lower IFN-y secretion by T 
cells in these mice, compared to mice that had their target sites excised one or two weeks 
· post-immunization. A different pattern of target site dependence was observed for 
secondary responses . Maximal secondary B and T cell responses occurred for target sites 
excised within 24 hours of immunization. This suggests that transfected Langerhans cells 
that migrate out of the target site and into draining lymph nodes within 24 hours of 
immunization are sufficient for the induction of memory responses . Alternatively , these 
secondary responses may have been initiated by antigen expression and antigen uptake 
occurring at the target site within 24 hours. 
Another explanation for these results ts that the migratory component of 
immunization that initiates the immune responses observed here and by Klinman et al 
(1998) may be free DNA that has dissociated extracellularly from gold beads and has 
been transported to lymph nodes or taken up by APCs that then carried the DNA to the 
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lymph nodes. However, since transfected epidermal dendritic cells have been observed 
following gene gun immunization (Condon et al, 1996), and since gene gun 
immunization delivers DNA-coated gold beads directly into cells (Tang et al, 1992), we 
think it is more likely that dendritic cells directly transfected in situ are responsible for 
raising the observed target site-independent low-level responses. 
Therefore , antigen expression by transfected Langerhans cells may be sufficient 
for raising low levels of primary responses and · for raising secondary responses, but 
antigen expression by keratinocytes that are also secreting an array of cytokines may 
amplify the immune response initiated by DNA immunization. 
Role of antigen expression at the muscle target site. In contrast to the skin 
immune system, the muscle is not developed for immune surveillance. There are fewer 
resi(Jent dendritic cells in the muscle that can take up antigen expressed by muscle cells, 
as compared with skin, although professional APCs can be recruited into the muscle 
during local injury (Hohlfeld and Engel, 1994). Our results show that antigen expression 
in muscle is unnecessary in raising antibody and CTL responses to i.m. immunization. 
Therefore, cells transfected at distal sites may be sufficient in raising these responses. 
The cells outside the muscle target site that initiate antibody and CTL responses 
may be bone marrow-derived cells that are transfected by free DNA transported through 
blood or lymph following i.m. injection. Such egress of injected DNA outside the 
injected muscle is likely due to the large volume (50 microliters) of saline injected into a 
small mouse muscle bundle (Davis et al, 1995). Moreover, i.m. immunization results in 
DNA being delivered extracellularly, and not directly into cells (Wolff et al, 1992). 
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Althou gh antigen expression following i.m. immunization has been observed only in the 
injected muscle (Wolff et al, 1990), plasmid DNA has been detected in blood 
immediately following i.m. injection, and elsewhere afterwards, includin g the spleen 
(Winegar et al, 1996). 
We speculate that the nonmuscle cells that are transfect ed followin g i.m. DNA 
injection are bone marrow-derived cells rather than nonhemopoietic cells . Plasmid -
bearin g dendritic cells have been observed in draining lymph nodes following i.m. 
injection (Casares et al, 1997). Immunization with dendritic cells transfected ex vivo has 
been shown to enhance immune responses in vivo (Manickan et al, 1997). In addition , 
only a few antigen-expre ssing and/or antigen-presenting dendritic cells ( ~ 100 to 1000) 
are sufficient for initiation of immune responses (Ludewig et al, 1998; Steinman , 1991 ) . 
Therefore , even if a small fraction of the large amount of injected DNA ( 100 micrograms 
= ~ 1013 molecules of DNA) leaves the tar get site, that fraction may be sufficient for 
tran sfecting the appropriate number of dendritic cells (Steinman, 1991 ) . Such low-level 
antigen expression by transfected dendritic cells may not be readily observed by 
conventional methods . 
Although we show that antigen expression in the muscle is unnece ssary for 
raising immune responses , others suggest that antigen expression by muscle cells may be 
sufficient. Transfected myoblasts have been shown in vitro to secrete antigen that is taken 
up and presented by APCs to antigen- specific MHC class II-restricted T cells (Casares et 
al, 1997) . Myoblasts transfected ex vivo have been shown to be sufficient for raising 
antibody and CTL responses in vivo upon transplantation into mice (Ulmer et al, 1996; 
64 
Fu et al, 1997). In the latter case, plasmid DNA and antigen expression are presumably 
confined to the transplanted myoblasts. However, transplantation of transfected 
myoblasts may not closely approximate what is occurring in vivo following i,m. 
immunization. The number of transfected myoblasts (107) injected into the mice in the 
study is more than 100,000 times greater than the actual number of antigen-expressing 
muscle cells observed following i.m. immunization (approximately 60 out of 4000 
muscle cells in the mouse quadriceps muscle; Wolff et al, 1990; Davis et al, 1994). In 
addition, myoblasts transplanted by i.m. and intra-peritoneal (i.p.) injections may 
circulate systemically and access bone marrow-derived APCs better than intact muscle 
cells, resulting in efficient presentation by APCs of antigen expressed by myoblasts. 
Myoblasts circulating systemically may also migrate into lymphoid tissue s, where the 
microenvironment may allow myoblasts to serve as antigen-presenting cells (Kundig et. 
al, 1995). 
A recent study where viral vectors were injected i.m. into mice supports our 
findings that antigen expression by muscle cells is not necessary for initiating immune 
responses (Jooss et al, 1998). The authors definitively showed that vector-directed 
antigen expression in muscle cells following i.m. injection is insufficient for raising 
immune responses, and that antigen expression by dendritic cells is both necessary and 
sufficient for initiating cellular responses. The authors compared two viral vectors, a 
recombinant adeno-associated virus (AA V) vector and a recombinant adenovirus (AdV) 
vector, both expressing ~-galactosidase. They showed that whereas both vectors 
. effectively transduced muscle cells resulting in ~-galactosidase expression, only the AdV 
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vector was able to initiate cellular and humoral responses. Through a senes of 
experiments, the authors were able to demonstrate that the different effectiveness of the 
two viral vectors in eliciting immune responses following i.m. injection was due to their 
different abilities in transducing dendritic cells . The transduction of dendritic cells by the 
AdV vector was directly responsible for its immunogenicity. 
Conclusion . Our findings suggest that antigen expression by bone marrow-derived 
cells plays a major role in initiation of immune responses by gene gun and i.m. DNA 
immunization . However, in gene gun immunizations , keratinocytes at the target site may 
play an important role in amplifying the immune response initiated by transfected 
Langerhans cells. 
CHAPTER II 
ROLE OF ANTIGEN PRESENTATION 
BY BONE MARROW-DERIVED CELLS 
IN THE INITIATION OF CTL RESPONSES 
BY DNA IMMUNIZATION 
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CHAPTER II 
ROLE OF ANTIGEN PRESENTATION BY BONE MARROW-DERIVED CELLS 





In the previous chapter, we examined the role of antigen expression at the target 
site in the initiation of antibody and CTL responses by DNA immunization . We showed 
that antigen expressiqn at the skin target site, presumably by keratinocytes, is necessary 
in initiation of maximal antibody and CTL responses following gene gun immunization. 
However, it is unknown whether keratinocytes were serving merely as a source of antigen 
for presentation by bone marrow-derived cells, or whether they were also processing and 
present ing the DNA vaccine-expressed antigen to initiate immune responses. In contrast, 
antigen expression by muscle cells was unnecessary in initiation of maximal antibody and 
CTL responses following i.m. immunization. It is therefore likely that nonmuscle cells at 
distal sites, perhaps bone marrow-derived cells in lymphoid tissues , were directly 
t ransfected, thus expressing as well as presenting the DNA vaccine-encoded antigen. 
Previous studies have demonstrated that antigen presentation by bone marrow-
derived cells is responsible for initiation of MHC class I-restricted CTL responses by i.m. 
DNA immunizat ion. One study involved the use of scid (severe combined 
5 This study was done in collaboration with Akiko Iwasaki and Dr. Brian Barber at the University of 
Toronto. Our contribution to this study involved immunization of mice by gene gun. 
6 The data presented in the chapter have been published by Iwasaki et al, 1997b . 
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immunodeficiency) mice that were either H-2b or H-2d infused with immunocompetent 
Fl H-2bxd spleen cells and immunized with plasmids encoding either herpes simplex virus 
glycoprotein B (gB) or human immunodeficiency virus glycoprotein (gpl20 ) (Doe et al, 
1996). By using an H-2b-restricted epitope from gB and an H-2d-restricted epitope from 
gpl20, the authors were able to detennine the haplotype specificity of the CTL responses 
in the chimeric mice . They found that the CTL responses were restricted to the haplotype 
of the recipient mice, which implies that antigen presentation by either bone marrow-
derived APCs or muscle cells in the recipient mice is responsible for initiation of these 
immune responses . However , infusion of bone marrow cells from Fl H-2bxd mice into the 
H-2d scid mice elicited CTL responses to both H-2b and H-2d, suggesting that antigen 
presentation by bone marrow-deri ved cells could elicit H-2b-restricted responses . 
However, these studies did not eliminate the possibility of antigen presentation by muscle 
cells of the scid recipient. 
Two other studies involved the use of bone marrow chimeric mice (H-2b ➔ H-
2bxd and H-2d ➔ H-2bxd) and i.m. immunization with influenza NP, in a similar manner as 
in this study (Corr et aJ, 1996; Fu et aJ, 1997). These studies demonstrated that the CTL 
responses in the chimeric mice were restricted to the haplotype of the bone marrow-
derived cells. 
In this chapter , we address the role of antigen presentation by bone marrow-
derived cells in initiation of MI-IC class I-restricted CTL responses following gene gun 
and i.m. immunization using bone marrow-chimeric mice. We extend the findings of the 
above groups to gene gun immunization . 
69 
:MHC restriction of C1L responses following DNA immunization was determined 
using bone marrow chimeric mice. Bone marrow chimeric mice have been used to 
demonstrate cross-priming of C1L to tumor alloantigens (Huang et al, 1994). H-2b ➔ H-
zbxd and H-2d ➔ H-zbxd bone marrow chimeric mice were constructed by reconstituting 
X-irradiated (C57BL/6 x BALB/c)Fl recipient mice with bone marrow from either 
C57BL/6 (H-2b) or BALB/c (H-2d) donors that had been depleted of T cells (Figure 20). 
It was verified by F ACS staining that the bone marrow-derived cells of the chimeric mice 
were of the donor haplotype (data not shown). 
It was determined whether H-2b ➔ H-zbxd could mount H-2d-restricted CTL 
responses, in order to verify that the T cell repertoire in the chimeric mice had been 
selected on both H-2b and H-2d. The H-2b ➔ H-zbxd chimeric mice were immunized with 
DBA/2 splenocytes presenting a minor histocompatibility antigen on H-2d, as described 
previously (Huang et al, 1994). C1L lysis of DBA/2-derived P815 target cells was 
observed in these mice, indicating that irradiation of the Fl mice prior to reconstitution 
with H-2b bone marrow does not preclude T cell antigen recognition in the context of H-
zd. This is expected since the radioresistant thymic epithelium in a bone marrow-
reconstituted mouse has been demonstrated to mediate positive selection of the T cell 
repertoire (Sprent et al, 1989). 
In the bone marrow chimeric mice, therefore, bone marrow-derived cells express 
:MHC class I proteins of the donor haplotype (either H-2b or H-2d) only, while 
nonhemopoiet ic cells, including keratinocytes in the skin and the muscle cells, express ~ 
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· Figure 20. Construction of parental into Fl bone marrow chimeras. See text for details. 
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MHC class I proteins of the Fl (H-2bxd) haplotypes. T cells of these chimeric mice, 
however, can recognize antigen in the context of both H-2b and H-2d. 
Using these bone marrow chimeric mice, it can be determined whether antigen 
presentation by hemopoietic cells or by nonhemopoietic cells activates precursor CTLs 
following DNA immunization by detennining the MHC restriction of the anti-NP CTL 
response . H-2b and H-2d-restricted CTL responses to influenza NP can be distinguished 
by the use of two peptides and two cell lines: NP(366-374), an H-2Db-restricted epitope, 
is presented by EL-4 (H-2~ cells; NP(147-155), an H-2Kd-restricted epitope, is 
presented by P815 (H-2~ cells. 
Role of antigen presentation by bone marrow-derived cells 
in initiation of CTL responses following gene gun immunization 
CTL responses following gene gun immunization were restricted to the haplotype 
of the donor bone marrow. The H-2b ➔ H-zbxd and the H-2d ➔ H-zbxd chimeric mice were 
immunized by gene gun with pCMV/NP, and boosted 3 weeks later. Two weeks post-
boost ,.CTL responses of responder cells from pools of two spleens were measured using 
the chromium release assay. Immunized H-2b ➔ H-zbxd mice generated antigen-specific 
CTLs restricted to H-2b (Figure 21) while immunized H-2d ➔ H-2bxd mice generated 
antigen-specific CTLs restricted to H-2d (Figure 22). Immunized Fl(H-2bxd) mice 
generated CTLs restricted to both haplotypes. This implies that antigen presentation by 
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Figure 21. H-2b-restricted CTL responses in bone marrow chimeric mice immunized by gene gun. Mice 
were immunized by gene gun with pCMV/NP or control vector pCMV and boosted at 4 weeks post-
immunization. Spleens were harvested 2 weeks post-boost. Specific lysis was determined using EL-4 (H-
2~ ceUs pulsed with NP (366-374). Representative results from each group of three to four mice are 
shown. 
Symbols: closed circle - H-2b ➔ H-2bxd mice immunized with pCMV /NP 
open circle - H-2d➔ H-2bxd mice immunized with pCMV/NP 
closed square - H-2bxd mice immunized with pCMV/NP 
open square - H-2bxd mice immunized with control vector pCMV 
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Figure 22. H-2d-restricted C1L responses in bone marrow chimeric mice immunized by gene gun. Mice 
were immunized by gene gun with pCMV/NP or control vector pCMV and boosted at 4 weeks post-
immuniz.ation. Spleens were harvested 2 weeks post-boost . Specific lysis was determined using P815 (H-
2d) cells pulsed with NP (147- 155). Representative results from each group of three to four mice are 
shown. 
Symbols: closed circle - H-2b ➔ H-2bxd mice immunized with pCMV/NP 
open circle - H-2d➔ H-2bxd mice immunized with pCMV/NP 
closed square - H-2bxd mice immunized with pCMV/NP 
open square - H-2bxd mice immunized with control vector pCMV 
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gun immunization, since antigen presentation by nonhemopoietic cells should be able to 
raise C1L responses restricted to the haplotype not expressed by the donor bone marrow 
cells, but expressed by nonhemopoietic cells. Control target cells that were not pulsed 
with NP peptide were lysed at minimal (<100/4) effector:target ratios. 
Role of antigen presentation by bone marrow-derived cells 
in initiation of CTL responses following i.m. immunization 
C1L responses following i.m. immunization were also restricted to the haplotype 
of the donor bone marrow. Mice were immunized intramuscularly and boosted at 3 
weeks post-immunization . CTL responses were assayed as in gene gun-immunized mice. 
imilar to the result s with gene gun immunization, antigen-specific C1L s raised in H-2b 
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➔ -2bxd were restricted to H-2b (Figure 23), while CTLs raised in H-2d ➔ H-2bxd mice 
were restricted to H-2d (Figure 24). Immunized F l(H-2 bxd) mice generated CTLs 
restricted to both haplotypes. Control target cells that were not pulsed with NP peptide 
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Figure 23. H-2b-restricted CIL responses in bone marrow chimeric mice immunized by i.nL injection. 
Mice were immunized by i.m. injection with pCMV/NP and boosted at 4 weeks post-immunization. 
Spleens were harvested 2 weeks post-boost. Specific lysis was determined usingEL-4 (H-2b) cells pulsed 
with NP (366-374). Representative results from each group of three to four mice are shown. 
Symbols: circle - H-2b ➔ H-2bxd mice immunized with pCMV/NP 
diamond - H-2d➔ H-2bxd mice immunized withpCMV/NP 
square - H-2bxd mice immunized with pCMV/NP 
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Figure 24. H-2d-restricted C1L responses in bone marrow chimeric mice immunized by i.m injection . 
Mice were immunized by i.m. injection with pCMV/NP and boosted at4 weeks post-immunization . 
Spleens were harv ested 2 weeks post-bo ost . Specific lysis was determined using P815 (H-2d) cells pub~ 
with NP (147-1 55). Representative results from each group of three to four mice are shown. 
Symbols : circ le - H-2b ➔ H-2bxd mice immunized with pCMV/NP 
diam ond - H-2 d ➔ H-2b"" mice immunized with pCMV/NP 
square - H-2bxd mice immunized with pCMV/NP 
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Discussion 
In summary, we found that CTL responses raised by both gene gun and i.m. 
immunizations were restricted to antigen presentation by bone marrow-d erived cells, and 
not to antigen presentation by nonhemopoietic cells tran sfected at the target site. The 
results demonstrating the role of antigen presentation by bone marrow-derived cells in 
i.m. immunizations verify results of other groups (Corr et al, 1996; Fu et al, 1997; Doe et 
al, 1996; Ulmer et al, 1996). In this study, we have extended this observation to gene gun 
immunization. 
Despite the requirement for antigen expression by keratinocyte s m initiating 
maximal antibody and CTL responses following gene gun immunization demonstrated in 
Chapter I, we found that antigen presentation only by bone marrow-derived cells (and not 
by nonhemopoietic cells) is relevant to raising these responses. Therefore, for gene gun 
immunization, keratinocytes may serve as a source of antigen and immunostimulatory 
cytokines, while Langerhans cells that are directly transfected , or that have taken up 
antigen from keratinocytes, appear to present antigen to initiate immune responses. 
Following DNA immunization by i.m. injection, antigen presentation that initiates 
MHC class I-restricted T cell responses is invariably by bone marrow-derived cells, and 
not by muscle ceJls. In addition, co-transfection with the costimulatory molecule B7-2 or 
co-immunization with plasmids expressing the cytokines IL-12 and GM-CSF does not 
convert nonhemopoietic cells into effective APCs (Iwasaki et al, 1997b ). 
These findings suggest that in the cases where antigen expression is presumed to 
be restricted to muscle cells ( e.g. following transplantation of transfected myoblasts; 
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Ulmer et al, 1996; Fu et al, 1997), there must be a mechanism of antigen transfer from 
muscle cell to professional APC for MHC class I presentation. Exogenous antigens may 
access a pathway for MHC class I presentation, which has been shown for tumor antigens 
(Huang et al, 1994; Udono and Srivastava, 1993), minor histocompatibility antigens 
(Arnold et al, 1995) and soluble antigens (Staerz et al, 1987; Reis e Sousa -and Germain, 
1995). This mechanism of antigen transfer for MHC class I presentation may involve 
macropinocytosis by macrophages or association of the antigen with heat shock proteins 
(Watts, 1997). 
Antigen presentation by bone marrow-derived cells has also been shown to be 
responsible for initiation of MHC class IT-restricted T cell responses following i.m. and 
i.d. DNA immunizations (Casares et al, 1997). Secreted antigens expressed by muscle 
cells would have access to the exogenous pathway for MHC class Il pathway. 
Intracellular and membrane-bound antigens may be released during cell death and thus 
access the exogenous pathway for MHC class II presentation. Alternatively, antigens 
expressed by transfected bone marrow-derived cells may access the endogenous pathway 
for MHC class II presentation (Lechler et al, 1996). 
CHAPTER III 
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CHAPTERID 
EFFECT OF SECRETION OF ANTIGEN 
ON ANTIBODY RESPONSES RAISED BY DNA IMMUNIZATION 
Introduction 
In the first chapter, we used different forms of antigen ( membrane-bound, 
intracellular and secreted) in examining the role of antigen expression at the target site in 
initiation of immune responses. We found that the form of antigen did not influence the 
role of the target site. However, it was unclear whether the form of antigen might affect 
the antibody response elicited by DNA immunization, since three distinct antigens were 
used to represent membrane-bound, intracellular and secreted forms. 
Antibody responses have been observed for both influenza NP, an intracellular 
antigen, and influenza HI , a membrane-bound antigen (Robinson et al, 1997). However, 
since these antigens are cell-associated, it might be expected that they would be less 
available than a secreted antigen for uptake by professional APCs. Furthermore, secreted 
antigens could easily reach lymphoid tissues in order to initiate immune responses 
(Zinkemagel et al, 1997). Therefore, it might be expected that a secreted antigen would 
raise greater antibody responses than a membrane-bound antigen. 
In this chapter, we examine the effect of secretion of influenza HI, a norm~ly 
membrane-bound protein, in raising antibody responses by DNA immunization . 
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Plasmids expressing either secreted or membrane-bound forms of influenza Hl 
Antibody responses to secreted HI and membrane-bound Hl were compared by 
immunizing BALB/c mice with either pJW4303/sHl or pJW4303/Hl (see Methods). The 
plasmid pJW4303/sHl was constructed by modifying pJW4303/Hl (Figure 25). A stop 
codon was introduced upstream of the sequence coding for the transmembrane domain of 
Hl. 
The secreted form of HI expressed from this plasmid retains T-helper epitopes 
(Gerhard et al, 1991) and the ability to form oligomers and to bind sialic acid (Gething et 
a~ 1986; Gething and Sambrook, 1981). The secreted fonn also retains neutralizing 
antibody epitopes (Caton et al, 1982; Wilson and Cox, 1990) However, a CTL epitope 
located in the transmembrane region of HI is deleted by the truncation (Kuwano et al, 
1989). 
Antigen-capture ELISA on cell lysates and culture supernatants from transiently 
transfected COS cells revealed that the total level of expression of the two plasmids was 
comparable (Table 1). Moreover , localization of the DNA vaccine-encoded Hl and sHl 
was as expected; HI was found only in cell lysates, while more than 90% of sHl was 
found in culture supematants. Secreted Hl in the process of synthesis and/or transport, or 
sHl that had been adsorbed onto the cell surface via binding to sialic acid, may account 
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Figure 25. HI and slU -expressing plasmids. Plasmids pJW4303/Hl and pJW4303/sH l are described in 
text (Methods). To construct pJW4303/sHl expressing secreted HI , a stop codon was introduced at nt. 
1623, prior to the transmembrane (IM) domain of the full-length HI. HAI, HA2 - subunits of influenza 
hemagglutinin HA; tridents - glycosylation sites; numbers refer to nucleotide bases; SV40 Ori- SV40 
origin; CMV Pro- cytomegalovirus promoter, with intron A:, BGH pA - bovine growth hormone 
polyadenylation sequence; pUC19 - plasmid pUC19 backbone 
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Table 1. Hl and sHl expression in transiently transfected COS cells 
Immunizing Total Antigen Culture Cell 
DNAa Expressionb Supernatan{ Lysatec 
experiment 1 pJW4303/Hl 889 < 889 
pJW4303/sHl 1255 1157 97 
experiment 2 pJW4303/Hl 931 < 931 
pJW4303/sHl 964 964 < 
a COS cells were transiently transfected with 10 µg of either pJW4303/Hl or 
pJW4303/sHl in two independent experiments as described in Materials and Methods . 
b Total antigen expression represents the sum of amounts of antigen detected in culture 
supernatants and cell lysates and are expressed in terms of HA units ( described in 
Materials and Methods). Expression of human growth hormone from co-transfected 
pWRG1602 showed equal transfection efficiencies for all plasmids and transfections . 
c Culture supematants and cell lysates were prepared at 72 hours post-transfection. 
Antibody responses in mice immunized with pJW4303/Bl or pJW4303 /sH1 
by gene gun 
84 
Immunization of BALB/c mice with secreted HI by gene gun immunization 
elicited lower levels of antibody than immunization with membrane-bound HI . Mice 
were immunized by gene gun with either 0.4 µg, 0.04 µg, or 0.004 µg of sHI- or HI-
expressing plasmid DNA Sera collected from individual mice at 12 weeks post-
immunization were examined by ELISA The 0.4 µg and 0.04 µg doses raised significant 
levels of antibody. Antibody responses to the 0.004 µg DNA dose were at background 
levels. The plasmid expressing sHI raised apparently lower levels of lgG than the 
plasmid expressing membrane-bound HI (Figure 26). 
Although the differences between the response to HI and sHl immunization were 
not significantly different at the 0.4 µg (P > 0.05) and the 0.04 µg (P > 0.05) DNA doses, 
there appeared to be a trend in the responses, with sHl eliciting lower responses than HI. 
Pre-immune sera and sera from mice immunized with control plasmids had no detectable 
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Figure 26. Dose response to gene gun immunization with either pJW4303/Hl or pJW4303 sHl.Mice 
were immunized with either Hl (open bars) or sHl (hatched bars) at the indicated doses. Sera were 
collected at 12 weeks post-immunization. Specific IgG levels were determined by ELISA. 
Data are represented as geometric mean titers ± geometric mean errors. Pre-immune sera and sera 
from mice immunized with control vector alone had no detectable specific lgG (data not shown). 
Antibody responses following 
primary gene gun immunization with pJW4303/Hl or pJW4303 /sB1 and 
secondary immunization with pJW4303/Hl or pJW4303 /sB1 
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Secreted Hl was less effective than membrane-bound Hl in boosting primary 
responses (Figure 27). Mice were immunized by gene gun with the suboptimal dose of 
0.04 µg pJW4303/Hl or 0.04 µg pJW4303/sHl , then boosted at 21 and 37 weeks post-
priming with either 0.04 µg pJW4303/sHl or 0.04 µg pJW4303/Hl . Sera were collected at 
45 weeks post-priming. 
Boosting HI-prim ed responses with sHl resulted in significantly lower antibody 
levels (P < 0.05) than boosting with HI (Figure 27A). In fact, boosting with sH l resulted 
in comparable levels of antibody as seen in unboosted mice. In contrast , boosting with 
membrane-bound Hl raised 6-fold higher responses than those seen in unboosted mice. 
Mice that were primed with sHl then boosted with sHl also had lower antibody 
levels (P < 0.05) than mice primed with sH l then boosted with membr ane-bound H l 
(Figure 27B) . Boosting with membrane-bound Hl raised antibody responses that were 9-
fold higher than responses in unboosted mice. In contrast, boosting with sHl raised 
antibody responses that were 5-fold higher than responses in mice immunized only once 
with sHl. 
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HI HI --> sHl HI --> Hl sHl sHl --> sHl sHJ --> Hl 
primary immunization --> boost primary immunization --> boost 
Figure 27. Secondary immunization with either pJW4303/H l or pJW4303/sHI. Mice were immuni zed with either pJW4303/Hl (A) or pJW4303/sHl 
(B) then boosted with either Hl or sHl DNA at 21 and 37 weeks post-priming. Sera were collected at 45 weeks post-priming. Specific IgG were 
determined by ELISA. Data are represented as geometric mean titers ± geometric mean errors. 
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Antibody responses in mice immunized with 
pJW4303/Hl or pJW4303/sH1 by i.m. injection 
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Secretion of HI also resulted in lower antibody responses following i.m. 
immunization (Figure 28). Mice received either 100 µg, IO µg or I µg of sHl- or HI -
expressing plasmid DNA. Sera collected from individual mice at 12 weeks post-
immunization were examined by ELISA. One hundred micrograms of DNA gave 
comparable responses for both sHI and HI (P > 0.05). However, 10 µg DNA resulted in 
6-fold _higher lgG levels for HI than sHI (P < 0.05). Pre-immune sera and sera from mice 
immunized with control plasmids had no detectable antigen-specific IgG ( data not 
shown). 
Antibody responses following co-immunization with pJW 4303/Hl and pJW 4303/sHl 
Co-immunization of secreted HI with membrane-bound HI did not enhance 
antibody responses to HI following either gene gun or i.m. immunization. Mice were 
immunized using the gene gun by co-delivery of gold beads that were coated with either 
pJW4303/Hl or pJW4303/sH1 (Figure 29). Immunizations delivered a total of 0.04 µg 
experimental DNA This suboptimal dose was chosen so as to be able to observe any 
c., 
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Figure 28. Dose response to i.m. immunization with either pJW4303/Hl or pJW4303/sH I. Mice 
were immunized with H I (open bars) or sHl (hatched bars) at the indicated .doses.Sera were 
collected at 12 weeks post-immunization . Specific lgG levels were determined by ELISA 
Data are represented as geometric mean titers ± geometric mean errors . Pre-immune sera and 
sera from mice immunized with control vector alone had no detectable specific IgG (data not shown). 
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Figure 29. Prepara tion of DNA-coated gold beads for co-immuniza tion of pJW4303/H l and pHW4303/sHl by gene gw1. Gold beads were coated 
separately with either con trol vector pJW4303, pJW4303/Hl or pJW4303/s H l . DNA-coated gold beads were combined and precipitated onto the inner 
surface ofa plastic tubing that was cut into individual shots. A total of three shots was given per mouse, delivering a tota l of0.04 µg experimental DNA 




increase in the antibody response to co-immunization with sHl and HI compared to 
immunization with HI alone. 
IgG levels measured at 12 weeks following co-immunization by gene gun with 
HI and sHl (around 7 µg/ml) were not significantly different (P > 0.05) than those in 
mice immunized with HI alone (around 10 µg/ml; Figure 30). Pre-immune sera had no 
detectable antigen-specific antibodies (data not shown). 
Mice were also immunized i.m. with a mixture of pJW4303/Hl and 
pJW4303/sH1 in saline. A suboptimal dose of IO µg DNA (5 µg of each DNA) was 
chosen for reasons cited above. IgG levels measured at 12 weeks following co-
immunization with Hl and sHI (around 6 µg/ml) were comparable to those in mice 
immunized with pJW4303/Hl alone (also around 4 µg/ml; Figure 31). Pre-immune sera 
had no detectable antigen-specific antibodies (data not shown). 
Predominant IgG subclass isotype raised by pJW4303/Hl and pJW4303/sH1 
Secretion of Hl influenced the predominant IgG subclass of the response to i. m. 
immunization (Table 2). Following gene gun immunization, the predominant IgG 
subclass isotype of the antibody response to both Hl and sHl was IgG l. However, 
following i.m. immunization, the predominant lgG subclass isotype of the response to HI 
was IgG2a, whereas the response to sHl was predominantly IgGI . The lgGI /IgG2ar atio 
of the response to HI following i.m. immunization was 0.2 while the lgG I/IgG2a ratio of 












Hl (Hl) + (sH l) 
gene gun immunization 
Figure 30. Co-immuniza tion ofpJW4 303/sH l with pJW4 303/Hl by gene gun. Mice were immunized 
with a total of0.0 4 µg total of HI only, or Hl and sHl coated on separate beads and delivered togethe r 
[(HI) + (sHl )). Sera were collected at 12 weeks post-immwrization. Specific IgG were determined by 
ELISA . Data are represented as geometric mean titer s ± geometric mean errors . Pre -immune sera had no 













H1 H1 + sH1 
DNA immunization 
Figure 31. Co-immunization ofpJW4303/sHI with pJW40 3/Hl by i.m. injections. Mice were 
immunized with 10 µg HI only or a mixtureof HI and sHl. Sera were collected at 12 weeks 
post-immunization. Specific lgG were determined by ELISA. Data are represented as 
geometric mean titers ± geometric mean errors. Pre-immune sera had no detectable specific 
IgG (data not shown). 
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Table 2 . Subclass of antigen -specific IgG generated after boosting in i.m. and gene gun DNA immunization. 
Route Vaccine Antigen-specific antibod {, µg/ml 
i.m. Immunizationa Timeb IgGl lgG2a IgG1/lgG2a 
100 µg Bl 
Primary 18 weeks 2.2 ± 0.7 9.0 ± 1.6 0.2 
24 weeks 2.8 ± 1.7 11.8 ± 2.0 0 .2 
Secondary 
36 weeks 4.4 + 0.6 18.4+3 .2 0.2 
100 µg sHl 
Primary 18 weeks 13.3 ± 4.1 2.2±0.9 6.0 
24 weeks 17.8 ± 4.6 4 .3 ± 1.7 4.1 
Secondary 
36 weeks 16.0 ± 5.9 3.5 ± 1.8 4.6 
gene gun 0.04 µgHl Primary 18 weeks 3. 1 1.0 3.1 
Secondary 24 weeks 23 .4 5.8 4.0 
0.04 µg sHl Primary 18 weeks < < NIA 
Secondary 24 weeks 22 .0 < NIA 
3 Secondary immunization s were done at 18 and 32 weeks post-priming for i.m. immunization, and at 21 weeks post-priming 
for gene gun immunization. 
bTime sera were collected for analysi s is given in weeks following primary immuniza tion. · 
cpor i.m. immunizations, values are means of individua l mouse serum IgG ± SEM. For gene gun immunization, value s are for 
pooled mouse sera. 
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The predominance of either lgGI or lgG2a in the responses to Hl or sHl , 
following gene gun or i.m. immunization, did not change with subsequent boosts. 
Secondary gene gun immunizations did not change the predominance of lgG I in the 
response to either sHl or HI. The lgG l/IgG2a ratio for secondary i. m. immunizat ions of 
HI remained at 0.2, with IgG2a still the predominant isotype. For secondary i.m. 
immunizations with sHI, the IgG l/IgG2a ratio was between 4 and 5, with lgG I still the 
predominant isotype. Secondary immunizations clearly did not change the ratio of IgG I 
to IgG2a, in contrast to results described for DNA immunization with the malaria 
circumsporozoite protein (Mor et al, 1995; Leitner et al, 1997). 
IL-4 dependence of the predominant lgGl response 
The predominantly IgGI response to i.m. immunization with secreted HI was 
dependent on endogenous IL-4 production (Table 3). A predominant lgG 1 response is 
characteristic of a Th2 response and is IL-4 dependent (Swain et al, 1991 ). To examine 
the IL-4 dependence of the IgGl response to i.m. immunization with sHl , IL-4 knock-out 
mice and control BALB/c mice were immunized intramuscularly with HI or sHl . IL-4 
knock-out mice and BALB/c mice were also immunized with H I by gene gun as control, 
since the dependence on IL-4 of the predominantly IgG 1 response to HI following gene 
gun immunization has been demonstrated (David Feltquate , unpublished data). Individual 
sera 
Table 3. lsotypes of antigen-specific antibody generated in IL-4 knockout mice and in wild type mice following DNA 
immunization with pJW4303n-Il or pJW4303/sH1 . 
Mouse Antigen-specific antibody, uglml 
Route Vaccine Genotype IgGl IgG2a IgG2b lgG3 IgA IgE 
i.m. 
100 µg Bl IL-4 -/- 3.0 ± 1.9 13.8 ± 3.4 3.7 ±0 .9 10.4 ± 3.3 < < 
IL-4 +/+ 1.4 ± 0.5 7.4 ± 1.9 2.7 ± 0.9 1.7 ± 0.6 < < 
100 µg sHl IL-4 -/- 1.2 ± 1.2 2 .9 ± 1.6 3.6±2.9 0.4 ± 0.4 < < 
IL-4 +/+ 7 .5 + 1.6 0.5 + 0.2 3 .1+ 0.9 < < < 
gene gun 
0.4 µgHl IL-4 -/- 3.9 ± 2.7 23.8 ± 9 12.0 ± 2.6 11.7 ± 4.2 < < 
IL-4 +/+ 11.3 ± 1.1 3.4 ± 1.7 7.7±2 .1 7.8 ± 2.4 < < 
Mice were immunized by i.m. injection with HI or sHI or by gene gun with HI . Sera were collected at 12 weeks post-
immunizati on. Levels of specific antibody isotypeswere determined by ELISA. Pre-immune sera and sera from mice 











were collected at 12 weeks post-immunization, and different antigen-specific antibody 
isotypes were assayed by ELISA. 
In IL-4 knock-out mice, the predominantly IgGl response seen in sHl-immunized 
BALB/c mice was lost following i.m. immunization . Following immunization with sHl, 
the serum IgG 1 level was more than 6-fold lower while the serum lgG2a level was 6-fold 
higher in IL-4 knock-out mice compared to BALB/c mice. This is consistent with the 
reciprocal regulation of the Thl and Th2 subsets (Swain et al, 1991; Rizzo et al, 1995). 
This resulted in a change of the IgGl/lgG2a ratio of the response to sHl from 15 in 
BALB/c to 0.4 in IL-4 knock-out mice, indicating a 'sw itch' in the response from a 
predominantly lgG 1 to a predominantly lgG2a response. In contrast , there was no change 
in the lgGI/lgG2a ratio of the response as compared with BALB/c mice following i.m. 
im_munization with H l, with the ratio holding at 0.2. 
For gene gun immunization with Hl, IL-4 knock-out mice had about 3-fold less 
lgGl and 7-fold more lgG2a than their BALB/c counterparts . This resulted in a change of 
lgG 1/lgG2a ratio from around 3 in BALB/c mice to 0.2 in IL-4 knock-out mice . 
The levels oflgG3 subclass isotype of the antibody responses to H l and sHl were 
also different between IL-4 knock-out and BALB/c mice, with IL-4 knock-out mice 
having higher (1.5- to 6-fold) lgG3 levels than their BALB/c counterparts . IgG3 is 
another isotype that is characteristic of Thl responses, since IL-4 can mediate 
suppression of lgG3 production by B cells (Tonkonogy et al, 1989), and Thl clones, in 
the absence of Th2 clones, support lgG3 production in vivo (DeKruyff et al, 1993). No 
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det..ectab}e IgA, lgE or IgM (data not shown) were observed in any of the immunized 
mice. Pre-immune sera had no detectable antigen-specific antibodies (data not shown). 
Relative affinities of antibodies to HI and sHl 
Secreted HI and membrane-bound HI elicited antibodies with comparable 
relative affinities following both gene gun and i.m. injection (Figure 32). Relative 
affinities of serum antibody samples were measured by ELISA using thiocyanate elution 
(Pullen et al, 1986; MacDonald et al, 1988). This ELISA employs graded concentrations 
of the chaotropic ion, thiocyanate (SCN) , to disrupt antigen-antibody interactions. 
Antibodies with greater relative affinities require higher concentrations of SCN to be 
eluted. The relative affinities of antibodies to both gene gun and i.m. immunization with 
both sHI and HI were comparable. The relative affinity curves for both antigens and for 
the two immunizations were overlapping, with their affinity indices ( concentration of 
NaSCN required for 50% reduction in antibody binding) being around 1.5 M NaSCN. 
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Figure 32. Relativ e affin.ities of antibodies raised by gene gun and i.m. immunization with 
pJW4303/H l and pJW4303/sHl. Mice were immunized either by gene gun (circles) or i.m . (squares) 
with either H I (closed symbols) or sHl (open symbols). Sera were collected at 12 weeks post -
immunization and pooled. Data are expressed as log 10 of percent of ini tial lgG bound (IgG bound 
in the absence of NaSCN). Third degree polynomial regression analysis was performed by 
Sigma Plot Software. A line at y = 1.699 (log 10 (50 % initial IgG bound]) was drawn paral lel to the 
x-axis.The point relative to the x-axis at which this line intersects the elution cwve for a parti cular 
sample represents the molar concentration ofNaSCN required to reduce bindin g oft.bat sample. 




In summary , immunization with secreted Hl elicited lower antibody responses 
compared to immunization with Hl. For gene gun immunizations , the reduction in 
antibody responses elicited by sH l was more clearly seen following boost, with sHI 
being less effective than HI at boosting antibody responses. Secretion of HI affected the 
isotype of the antibody response raised by i.m. injection. Secreted HI raised a 
predominantly lgGl response , while Hl raised a predominantly lgG2a response. The 
prtdominantly lgG 1 response to sHl was rr.,.4 dependent. 
Our observation that secretion of Hl did not enhance antibody responses to Hl 
is cor1sistent with observations for other antigens (Table 4) . DNA immunization with 
plasmids encoding a chimeric malaria antigen with or without a secretion signal raised 
comparable antibody levels (Haddad et al, 1997). Secretion of bovine herpesvirus 
glycoprotein D (Babiuk et al, 1995) and of rabies G protein (Ertl et al, 1995; Xiang et al, 
1995) also did not enhance antibody responses . 
In contrast , other investigators have observed enhanced antibody responses to 
secreted forms compared to nonsecreted forms of DNA-encoded antigens (Table 4) . 
Secreted forms of hepatitis C virus nucleocapsid (Inchauspe et al, 1997) and ovalbumin 
(Boyle et al, 1997) and malaria antigens (Gardner et al, 1996) have raised higher antibody 
responses than the corresponding nonsecreted forms. The secreted hepatitis B virus e 
antigen also raised higher antibody responses than the intracellular core antigen (Sallberg 
et al, 1997). The hepat itis B virus e and core antigens differ only by their amino termini, 
Table 4. Compar ison of ant ibody and T-helper responses raised in mice by i.m. immunization with different forms (localization) of DNA vaccine-
encoded antigens 
Longevity of Relative Predominant 
Antigen Localization of antibody (Ab) magnitude of Ab isotype of Ab 
antigen res~onse• . res~ nses res~onse T-hel~er res~onse Reference 
Influenza HI plasma membrane• long-term plasma membrane > lgG2a ND Figure 26-28; 
secreted# long-term secretec!® lgGI NDb Tables2 & 3 
Measles plasma membrane+ long-tenn lgG2a ND K. Yang, 
hemagglutinin H ND unpublished results 
secreted# long-term IgGJ ND 
rabies G protein plasma membrane+ long-term plasma membrane= ND ND Xiang et al, 1995 
secreted long-term secreted® ND ND 
ovalbumin plasma membrane ND (plasma membrane= lgG2a ND Boyle et al, I 997 
intracellular ND intracellular) lgG2a ND 
secrete~ ND < secreted lgGJ ND 
bovine herpesvirus plasma membrane+ long-tenn plasma membrane = lgG2a Thi Babiulc et al, 1995; 
glycoprotein D intracellular long-term intracellular = IgG2a Thi Lewis et al, 1997 
secreted# long-term secreted lgGJ Thi 
Hepatitis B virus core antigen•·c ND core antigen < lgG2b/lgG2ad Told Sellberg et el, 1997 
e antigen +,c ND e antigen IgGld Th2d 
Hepatitis C virus intracellular• long-term intracellular< IgG2a Thi Inchauspe et al, I 997 
nucleocapsid secreted# long-term secreted IgG2a Thi 
malaria N4 (derived intracellular• long-term intracellular= ND ND Haddad et al, 1997 
from Pf332 antigen) secreted° long-term secreted ND ND 
... nonnal localization of the antigen, prior to modification; 1 secretion is due to truncation of antigen, i.e. removal of the transmembrane region of the nonnal antigen 
• secretion is due to addition of the human tissue plasminogen activator sequence;@ antibody responses were compared at different DNA doses- for the other antigens, 
responses were measured for optimal DNA doses; ND - not detennined ; • Long-tem1 responses are maximal for> 12 weeks post-immunization, single dose; b JgG I 
response is Il--4-dependent. • Hepatitis B virus e antigen is secreted, while core antigen is intracellular ( see text) d Predominant isotypes differ for different MHC 






where the e antigen has 9 amino-acid long signal peptide, which is absent in the core 
antigen. Apparently, whether a secreted antigen raises higher responses than a 
nonsecreted form may depend on the antigen itself. 
The lower responses to sHI may be due to lower local concentrations of the 
secreted form of HI compared to the membrane-bound form. A soluble antigen can be 
expected to diffuse away from the site of expression, while multiple copies of a 
membrane-bound antigen would remain associated to the antigen-expressing cell. The 
comparable responses seen for HI and sH l following i.m. immunization with I 00 µg 
DNA is due to this large dose of DNA being at the plateau range of the dose response 
curve, where responses are maximal. The bigger difference seen between HI and sHl for 
i.m. immunization compared to gene gun may be due to responses following i.m. 
immunization being raised in the spleen, while responses following gene gun are raised in 
the lymph nodes (Christine Boyle, unpublished data). Differences in local antigen 
concentration may be greater in the spleen than in the draining lymph nodes, since the 
spleen has a larger volume than a lymph node. 
Although immunization with sHl resulted in apparently lower responses than 
immunization with membrane-bound HI, immunization with sHI by either gene gun or 
i.m. raised responses that protected animals from lethal viral challenge (data not shown). 
This indicates that the responses elicited by secreted HI were functional and effective. 
Implications of results on mechanism of initiation of immune responses by DNA 
immunization. The failure of secretion of H I to enhance antibody responses following 
DNA immunization suggests that a secreted antigen may not necessarily have better 
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access than a cell-associated antigen to lymphoid tissues or to uptake by APCs or B cells 
and subsequent MHC class II presentation. Similarly, secreted and non-secreted rabies 
glycoprotein were observed to result in comparable T-helper activation (Ertl and Xiang, 
1996). Preliminary experiment s have also demonstrated similar levels of antigen-specific 
T cell proliferative responses in Hl- and sHl-immunized mice (data not shown). These 
observations are surprising, since proteins are presented in the context of MHC class II 
when they are taken up exogenously, e.g. as soluble protein (Morrison et al, 1986). 
However, exceptions to that rule have been demonstrated. Studies have shown that hen 
egg lysozyme (HEL) that is endogenously synthesized by B cell lines are more efficiently 
presented ( up to 1000 times more) by the MHC class II pathway than HEL taken up 
exogenously (Brooks et al, 1991). In addition, MHC class II presentation of 
endogenously synthesized nonsecreted glycoproteins of the noncytopathic lymphocytic 
choriomeningitis virus (LCMV) has been described (Oxenius et al, 1995; Oxenius et al, 
1997). 
There are several models for the mechanism of presentation of endogenous 
proteins by MHC class II (Lechler et al, 1996; Sant, 1994; De Nagel and Pierce, 1991). 
Endogenously synthesized proteins that reach the cell surface may be endocytosed and 
thus are presented by MHC class II in a similar fashion as exogenous proteins. 
Alternatively, peptides or partially unfolded proteins may associate with MHC class II 
molecules in the endoplasmic reticulum; or cytosolic proteins may enter lysosomes by 
autophagy, or in association with heat shock proteins. 
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MHC class II presentation of endogenously synthesized antigen may result from 
direct transfection of bone marrow-derived cells, which constitutively express :Mlf C 
class II molecules (Steinman et al, 1993). Although nonhemopoiet ic cells such as 
keratinocytes and muscle cells can be induced by IFN-y to express MHC class II (Chu et 
al, 1989; Hohlfeld and Engel, 1994), they have neither the antigen processing 
'machinery' nor the costimulatory molecules required for them to initiate immunity. 
Instead, antigen presentation by keratinocytes and inuscle cells induce toleran ce 0)/ arrens 
et al, 1994; Gaspari et al, 1988). 
The failure of secretion of HI to enhance antibody responses also suggests that 
cell association of a DNA vaccine-encoded antigen does not result in confinement of that 
antigen to the periphery. According to a model proposed by Zinkemagel et al (1997), an 
antigen must not be confined to the periphery but must reach the lymphoid tissues at 
sufficient doses in order to initiate an immune response. A DNA vaccine-encoded 
membrane-bound antigen would be expected to remain associated with the transfected 
cell. If the only transfected cells are the non-migratory, nonhemopoietic cells at the target 
site, then a membrane-bound antigen would be confined to the periphery, i.e. at the target 
site, and would not reach the lymphoid tissues at doses sufficient enough to initiate an 
immune response. In contrast, a secreted antigen, even when expressed only in the 
periphery, would be able to reach the lymphoid tissues and initiate an immune response. 
On the other hand, if there are bone marrow-derived cells that are transfected and 
expressing the antigen, then these transfected lymphoid cells, which would home to the 
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lymphoid tissues, would be sufficient for raising an immune response, whether the 
antigen was secreted or membrane-bound. 
Therefore, it may be speculated that the maximal antibody responses seen for the 
membrane-bound form of HJ may be due to Hl being expressed by transfected bone 
marrow-derived cells that home to the lymphoid tissues where they initiate immune 
responses. The observation of dendritic cells bearing DNA and/or antigen in the lymph 
nodes following DNA immunization by gene gun (Condon et al, 1996) and by i.m. or i.d. 
injection (Casares et al, 1997), and of antibody and cytokine-secreting cells localized in 
the draining lymph node and spleen following i.m. immunization (Mor et al, l 995), are 
consistent with this speculation. 
An alternative explanation for the ability of a membrane-bound antigen to raise 
maximal antibody responses would be that membrane-bound antigens are presented in 
the context of MHC class Il on professional APCs following release of antigen from the 
transfected nonhemopoietic cell during cell death. In this case, transfection of APCs 
would not be necessary in raising an antibody response to membrane-bound antigens. 
Although release of antigen ( secreted or membrane-bound) from transf ected 
nonhemopoietic cells for subsequent MHC class II presentation may also be occurring, it 
is likely that transfection of bone marrow-derived dendritic cells is a more efficient 
mechanism by which low doses of antigen expressed from DNA vaccines are able to 
raise immune responses, rather than induce tolerance. Thus, our results in Chapter III 
support our speculation in Chapters I and Il that transfected bone marrow-derived cells 
initiate immune responses raised by DNA immunization. 
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IgG1/lgG2a responses to sHl and HI . The most striking difference between the 
antibody responses to sHl and HI is the predominant IgG subclass isotype of these 
responses following i.m. immunization . Secreted HI raised predominantly IgGl whereas 
HI raised predominantly lgG2a. Others have shown a similar IgG l/IgG2a dichotomy 
between antibody responses raised for secreted and nonsecreted proteins (Table 4). DNA 
immunizations with different forms of ovalbumin (Boyle et al, 1997), with measles 
hemagglutinin (Kejian Yang, unpublished data), with bovine herpesvirus glycoprotein D 
(Lewis et al, 1997) and with hepatitis B virus core (nonsecreted) and e (secreted) antigens 
(Sallberg et al, 1997) have resulted in a predominantly IgG I response towards the 
secreted form, and a predominantly IgG2a response towards the nonsecreted form. This 
dichotomy of the response to secreted and nonsecreted forms following DNA 
immuniz~ion has been speculated to be due to different abilities to prime B cells (Boyle 
et al, 1997), and may be Mlf C-dependent (Sall berg et al, 1997). 
We speculated that the lgG1/IgG2a dichotomy of the response to sHl and HI 
following i.m. immunization may be due to presentation of sHl , and not of HI, by B 
cells. Antigen presentation by B cells has been demonstrated to result in IL-4 secretion by 
T-helper cells in vitro (Stockinger et al, 1996) and Th2 responses (Taylor-Robinson and 
Phillips, 1996; Hernandez et al, 1997) and lgGl production in vivo (Kalberer et al, 1997; 
Macaulay et al, 1998). In addition, antigen presentation by B cells may play a central role 
under conditions of limiting amounts of soluble antigen (Abbas, 1988). Antigen 
presentation by B cells in the presence of low doses of antigen has been demonstrated to 
ind~ce Th2 types of responses (Secrist et al, 1995; DeKruyff et al, 1992). However, we 
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found in pilot cell proliferation experiments that splenic cells from B cell-deficient µMT 
mice immunized with either sHl or HI had similar recall proliferation responses ( data 
not shown). This may imply either that antigen presentation of sHl by B cells is not 
important in raising antibody responses to sHI , or that antigen presentation by other 
APCs, such as dendritic cells, may be sufficient in compensating for the ·absence of 
antigen presentation by B cells. Studies on the Th type of response elicited by sHI and 
Hl in these B cell deficient mice need to be done in order to investigate the role of B 
cells in presenting sHl and eliciting Th2 responses. However, such studies are 
complicated by the small cell numbers-in spleens of the µMT mice (Kitamura et al, 
1991). 
There are other possible explanations for the IgG 1/lgG2a dichotomy observed for 
sHl and H 1. The antigen dose can influence the Th type of response elicited ( Guery et al, 
1996; Hosken et al, 1995), not only by affecting the type of APC that presents the 
antigen, as mentioned above. Different antigen doses can also affect Th 1 or Th2 
differentiation due to the effect of antigen dose on ligand density on the APC, and on T 
cell receptor signaling (Constant et al, 1995; Tao et al, 1997; Constant and Bottomly, 
1997), both of which may be influenced by the MHC genotype of the immunized mice 
(Schountz et al, 1996; Murray, 1998; Conboy; et al, 1997; Hsieh et al, 1995). Further 
studies need to be done in order to examine the cause of the dichotomy of the response to 
sHl and Hl following i.m. immunization. 
The predominant ly IgG 1 or IgG2a responses we observed for sHl or HI did not 
.switch to the alternative type of the response following subsequent boosts, either for gene 
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gun or i.m. immunization. The stability of the IgGI/lgG2a ratio of the antibody response 
to HI (Feltquate et al, 1997; Deck et al, 1997) as well as to influenza NP (Pertmer et al, 
1996) following secondary DNA immunizations has been demonstrated before . Here we 
demonstrate that the lgG l/lgG2a of the response to sHl is also stable. This is in contrast 
with reports for another secreted antigen, the malaria circumsporozoite protein (CSP) 
from Plasmodium berghei (Leitner et al, 1997) and Plasmodium yoelii (Mor et al, 1995). 
Secondary immunizations with CSP DNA resulted in a switch of the response from lgG I 
to a mix of lgG 1 and lgG2a for gene gun immunization, or from IgG2a to mix (P. 
berghei) and IgGI to IgG2a (P. yoelii) for i.m. immunization. In contrast, a progression 
from IFN-y (Thl) to Il,-4 (Th2) secretion by spleen cells in vitro following gene gun 
immunization with human immunodeficiency virus (HIV) glycoprotein 120 has been 
observed (Fuller and Haynes, 1994). 
It has been speculated that secondary DNA immunizations result in an increased 
number of antigen-specific B cells that are then reactive to ISS on the plasmids delivered 
(Leitner et al, 1997), or in a shift in antigen processing or presentation by APCs (Mor et 
al, 1995). These factors did not result in a shift in the response to either sHl or HI in our 
studies. Perhaps the shift in the isotype of the response from IgG 1 to lgG2a with 
secondary immunizations is idiosyncratic for some antigens, such as malaria CSP. 
SUMMARY AND OVERVIEW 
110 
SUMMARY AND OVERVIEW 
When we began this study, the mechanism of initiation of immune responses by 
DNA immunization was unknown. The role of antigen expression by the transfected cells 
at the target site was one intriguing aspect of DNA immunization. Another was the role 
of antigen presentation by bone marrow-derived cells. It was also of interest what the 
effect of secretion of an antigen might have on antibody responses. 
In this dissertation, we demonstrate that for gene gun immunization, the skin 
target site is required for initiation of maximal antibody and CTL responses, while the 
muscle target site following i.m. immunization is not. For both gene gun and i.m. 
immunizations , antibody and CTL responses are initiated by antigen presentation by bone 
marrow-derived cells. We also demonstrate that secretion of influenza Hl lowers rather 
than enhances antibody responses. 
Proposed mechanism of initiation of immune responses by DNA immunization 
Based on the results presented in this dissertation, as well as results from other 
investigators discussed in the Chapters, we would like to propose a possible mechanism 
of initiation of immune responses by DNA immunization (Figure 33). 
Following inoculation of the animal with plasmid DNA, both nonhemopoietic 
cells at the target site of inoculation, as well as bone marrow-derived cells that are either 
resident at or trafficking through the target site, are transfected with DNA. These cells 
then express the antigen. 
Lymph Nodes, $pleen 
Figure JJ. Proposed model for the mechanism of initiation of immwte responses by DNA immwtization. See text for details. ELC - epidermal 
Langerhans cells; Ag - antigen; BMD APC - bone marrow-derived antigen-presenting cells; ASC - antibody-secreting cells; BM - bone marrow; Ag-
Ab - antigen-antibody 
...... ...... ...... 
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In gene gun immunization , bone marrow-derived cells (Langerhans cells) are 
transfected in situ, then migrate to the draining lymph node . In i.m. immunizat ion, DNA 
may be transported through blood and/or lymph, and may transfect bone marro w-derived 
cells in lymphoid tissues, i.e. the spleen . For both methods of immuniz ation , non-
transfected bone marrow-deri ved cells that pick up antigen expressed by transfected 
nonhemopoietic cells also migrate to lymphoid organs and initiate immune response s 
there . 
For gene gun immunization, keratinocytes are necessary for initiating maximal 
immune responses , although antigen express ion by Langerhans cells may be sufficie nt in 
raising low- level responses. Keratinocytes may amplify DNA-initiated responses due to 
their secretion of immuno stimu latory cytokines as well as their express ion of antigen . For 
i.m. immunization, antigen expre ssion by bone marrow-derived cells at distal sites is 
sufficient in ra ising maximal responses . 
Antigen expressed by transfected bone marrow-deri ved cells is presented 
endogeno usly in the context of MHC class I to initiate CTI, responses . These antigens 
are also presented in the context of MHC class II via an endogenous pathway and thu s 
initiate I -helper and B cell responses. Such endogeno us presentation in the context of 
both MHC class I and MHC clas s II by bone marrow-derived cells is highly efficient and 
may play a principal role in initiatin g the responses to DNA immunization . 
Antigen ( secreted , intracellular or membrane-bound) expressed by 
nonhemopoietic cells may get transferred to bone marrow -derived cells for subsequent 
presentation in the context of MHC class I by an exogenous pathway. Secreted antigen s 
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expressed by nonhemopoietic cells may also be taken up by bone marrow-derived cells 
for subsequent MHC class II presentation. Membrane-bound and intracellular antigens 
expressed by nonhemopoietic cells may also be released during cell death for subsequent 
presentation via MHC class II on bone marrow-derived cells. Antigen presentation 
relying on release of antigens due to cell death or secretion may be less efficient than 
endogenous presentation by transfected dendritic cells, but may serve to amplify the 
immune response to DNA immunization. 
Future Directions 
The results presented in this dissertation, taken in the context of findings by other 
investigators, have allowed us to formulate a tentative mechanism for the initiation of 
immune responses by DNA immunization. However, further work is required to elucidate 
the mechanism of DNA immunization. Although surgical excision and grafting 
experiments have shed light on the role of antigen expression at the skin target site, the 
role of antigen expression by specific cell types remains to be conclusively shown. We 
suggest here that keratinocytes are necessary for initiation of maximal antibody responses 
by gene gun immunization. However, conclusive studies where antigen expression is 
restricted to keratinocytes only or to Langerhans cells only, e.g. by use of tissue-specific 
promoters , are needed to substantiate this idea. 
It would also be of value to the field of DNA vaccines to elucidate the mechanism 
by which APCs process DNA vaccine-encoded antigens, whether through the 
endogenous or the exogenous pathways of MHC class I and MHC class II presentation. If 
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antigen transfer from non-transfected cells to bone marrow-derived cells plays a major 
role in initiation of MHC class I-restricted responses, then DNA vaccines might be 
designed that optimize such antigen transfer, perhaps by constructing DNA vaccines that 
encode for heat shock proteins in association with the antigen of interest. If endogenous 
MHC class II presentation by APCs is indeed important for DNA immunization, then 
DNA vaccines could be designed that optimize targeting of endogenously synthesized 
antigens to endosomes . Our finding that antigen presentation occurs via bone marrow-
derived cells and not via transfected nonhemopoietic cells suggests that studies should 
focus on maximizing recruitment of, and antigen presentation by, bone marrow-derived 
cells, through the use, for example, of cytokine-expressing plasmids. 
The mechanism by which different forms of an antigen can elicit different types 
of an~ibody or T-helper responses also needs to be clarified. The use of secreted and 
membrane-bound forms of a well-understood antigen such as influenza Hl may be a 
convenient model for examining the mechanism by which different T-helper responses 
are raised . This is relevant to the design of DNA vaccines that raise a desired T-helper 
type of immune responses, and will also contribute to the study of I -helper 
differentiation . 
Studies elucidating the mechanism of initiation of immune responses raised by 
DNA immunization are invaluable both to the field of DNA vaccines as well as to the 
science of immunology . Understanding how DNA vaccines work will lead to the 
optimization of this new technology and, hopefully, to its success in battling numerous 
pathogens and diseases . In addition, comprehension of the immunological processes 
115 
involved in DNA immunization should lead to models that will further our knowledge on 
how the immune system works . 
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